{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:04:10Z","timestamp":1793257450618,"version":"4.5.0"},"publisher-location":"Cham","reference-count":233,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032231710","type":"print"},{"value":"9783032231727","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-23172-7_6","type":"book-chapter","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:50:40Z","timestamp":1777596640000},"page":"101-146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Carbonic Anhydrase Inhibitors in Oncology"],"prefix":"10.1007","author":[{"given":"Claudiu T.","family":"Supuran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"issue":"4","key":"6_CR1","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/sj.bjc.6605200","volume":"101","author":"JK Ahlskog","year":"2009","unstructured":"Ahlskog JK, Schliemann C, M\u00e5rlind J, Qureshi U, Ammar A, Pedley RB, Neri D (2009) Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours. Br J Cancer 101(4):645\u2013657","journal-title":"Br J Cancer"},{"issue":"38","key":"6_CR2","doi-asserted-by":"publisher","first-page":"16233","DOI":"10.1073\/pnas.0908301106","volume":"106","author":"V Alterio","year":"2009","unstructured":"Alterio V, Hilvo M, Di Fiore A, Supuran CT, Pan P, Parkkila S, Scaloni A, Pastorek J, Pastorekova S, Pedone C, Scozzafava A, Monti SM, De Simone G (2009) Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX. Proc Natl Acad Sci USA 106(38):16233\u201316238","journal-title":"Proc Natl Acad Sci USA"},{"issue":"24","key":"6_CR3","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.1016\/j.jmb.2019.10.022","volume":"431","author":"V Alterio","year":"2019","unstructured":"Alterio V, Kellner M, Esposito D, Liesche-Starnecker F, Bua S, Supuran CT, Monti SM, Zeidler R, De Simone G (2019) Biochemical and structural insights into carbonic anhydrase XII\/Fab6A10 complex. J Mol Biol 431(24):4910\u20134921","journal-title":"J Mol Biol"},{"issue":"7682","key":"6_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nature24637","volume":"551","author":"SW Alvarez","year":"2017","unstructured":"Alvarez SW, Sviderskiy VO, Terzi EM, Papagiannakopoulos T, Moreira AL, Adams S, Sabatini DM, Birsoy K, Possemato R (2017) NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature 551(7682):639\u2013643","journal-title":"Nature"},{"issue":"1","key":"6_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00428-002-0721-y","volume":"442","author":"Y Akisawa","year":"2003","unstructured":"Akisawa Y, Nishimori I, Taniuchi K, Okamoto N, Takeuchi T, Sonobe H, Ohtsuki Y, Onishi S (2003) Expression of carbonic anhydrase-related protein CA-RP VIII in non-small cell lung cancer. Virchows Arch 442(1):66\u201370","journal-title":"Virchows Arch"},{"issue":"10","key":"6_CR6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3390\/metabo10100412","volume":"10","author":"A Angeli","year":"2020","unstructured":"Angeli A, Carta F, Nocentini A, Winum JY, Zalubovskis R, Akdemir A, Onnis V, Eldehna WM, Capasso C, Simone G, Monti SM, Carradori S, Donald WA, Dedhar S, Supuran CT (2020) Carbonic anhydrase inhibitors targeting metabolism and tumor microenvironment. Metabolites 10(10):412","journal-title":"Metabolites"},{"issue":"2","key":"6_CR7","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1021\/acs.jmedchem.2c01911","volume":"66","author":"A Angeli","year":"2023","unstructured":"Angeli A, Micheli L, Carta F, Ferraroni M, Pirali T, Fernandez Carvajal A, Ferrer Montiel A, Di Cesare ML, Ghelardini C, Supuran CT (2023) First-in-class dual hybrid carbonic anhydrase inhibitors and transient receptor potential Vanilloid 1 agonists revert Oxaliplatin-induced neuropathy. J Med Chem 66(2):1616\u20131633","journal-title":"J Med Chem"},{"key":"6_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115783","volume":"260","author":"A Angeli","year":"2023","unstructured":"Angeli A, Micheli L, Turnaturi R, Pasquinucci L, Parenti C, Alterio V, Di Fiore A, De Simone G, Monti SM, Carta F, Di Cesare Mannelli L, Ghelardini C, Supuran CT (2023) Discovery of a novel series of potent carbonic anhydrase inhibitors with selective affinity for \u03bc opioid receptor for safer and long-lasting analgesia. Eur J Med Chem 260:115783","journal-title":"Eur J Med Chem"},{"issue":"47","key":"6_CR9","doi-asserted-by":"publisher","first-page":"44497","DOI":"10.1021\/acsomega.3c01934","volume":"8","author":"A Annu\u0161ov\u00e1","year":"2023","unstructured":"Annu\u0161ov\u00e1 A, Labudov\u00e1 M, Truchan D, Heged\u0171\u0161ov\u00e1 V, \u0160vajdlenkov\u00e1 H, Mi\u010du\u0161\u00edk M, Kotl\u00e1r M, Pribusov\u00e1 Slu\u0161n\u00e1 L, Hulman M, Salehtash F, K\u00e1losi A, Cs\u00e1derov\u00e1 L, \u0160vastov\u00e1 E, \u0160iffalovi\u010d P, Jergel M, Pastorekov\u00e1 S, Majkov\u00e1 E (2023) Selective tumor hypoxia targeting using M75 antibody conjugated photothermally active MoOx nanoparticles. ACS Omega 8(47):44497\u201344513","journal-title":"ACS Omega"},{"issue":"23","key":"6_CR10","doi-asserted-by":"publisher","first-page":"7017e20","DOI":"10.1016\/j.bmcl.2011.09.102","volume":"21","author":"C Asakawa","year":"2011","unstructured":"Asakawa C, Ogawa M, Kumata K, Fujinaga M, Yamasaki T, Xie L et al (2011) Radiosynthesis of three [11C] ureido-substituted benzenesulfonamides as PET probes for carbonic anhydrase IX in tumors. Bioorg Med Chem Lett 21(23):7017e20","journal-title":"Bioorg Med Chem Lett"},{"issue":"29","key":"6_CR11","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.2174\/138161210793429823","volume":"16","author":"A Aspatwar","year":"2010","unstructured":"Aspatwar A, Tolvanen ME, Ortutay C, Parkkila S (2010) Carbonic anhydrase related protein VIII and its role in neurodegeneration and cancer. Curr Pharm Des 16(29):3264\u20133276","journal-title":"Curr Pharm Des"},{"issue":"6","key":"6_CR12","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.3109\/14756366.2012.727813","volume":"28","author":"A Aspatwar","year":"2013","unstructured":"Aspatwar A, Tolvanen ME, Parkkila S (2013) An update on carbonic anhydrase-related proteins VIII, X and XI. J Enzyme Inhib Med Chem 28(6):1129\u20131142","journal-title":"J Enzyme Inhib Med Chem"},{"key":"6_CR13","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/978-94-007-7359-2_8","volume":"75","author":"A Aspatwar","year":"2014","unstructured":"Aspatwar A, Tolvanen ME, Ortutay C, Parkkila S (2014) Carbonic anhydrase related proteins: molecular biology and evolution. Subcell Biochem 75:135\u2013156","journal-title":"Subcell Biochem"},{"issue":"2","key":"6_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1113\/JP283579","volume":"601","author":"A Aspatwar","year":"2023","unstructured":"Aspatwar A, Supuran CT, Waheed A, Sly WS, Parkkila S (2023) Mitochondrial carbonic anhydrase VA and VB: properties and roles in health and disease. J Physiol 601(2):257\u2013274","journal-title":"J Physiol"},{"issue":"10","key":"6_CR15","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1158\/1078-0432.CCR-04-2019","volume":"11","author":"M Atkins","year":"2005","unstructured":"Atkins M, Regan M, McDermott D et al (2005) Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer. Clin Cancer Res 11(10):3714\u20133721","journal-title":"Clin Cancer Res"},{"issue":"4","key":"6_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s10616-025-00815-6","volume":"77","author":"S Aydo\u011fan T\u00fcrko\u011flu","year":"2025","unstructured":"Aydo\u011fan T\u00fcrko\u011flu S, Okuyan D, K\u00f6\u00e7kar F (2025) The reducing effect of TNF-\u03b1 on carbonic anhydrase III gene expression in colon carcinoma and osteosarcoma cells. Cytotechnology 77(4):148","journal-title":"Cytotechnology"},{"issue":"5","key":"6_CR17","doi-asserted-by":"publisher","first-page":"3641","DOI":"10.1111\/jcmm.14265","volume":"23","author":"R B\u00e1nov\u00e1 Vuli\u0107","year":"2019","unstructured":"B\u00e1nov\u00e1 Vuli\u0107 R, Zdurien\u010d\u00edkov\u00e1 M, Ty\u010diakov\u00e1 S, Benada O, Dubrov\u010d\u00e1kov\u00e1 M, Lakota J, \u0160kult\u00e9ty \u013d (2019) Silencing of carbonic anhydrase I enhances the malignant potential of exosomes secreted by prostatic tumour cells. J Cell Mol Med 23(5):3641\u20133655","journal-title":"J Cell Mol Med"},{"issue":"4","key":"6_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/ana.20238","volume":"56","author":"L Bataller","year":"2004","unstructured":"Bataller L, Sabater L, Saiz A, Serra C, Claramonte B, Graus F (2004) Carbonic anhydrase-related protein VIII: autoantigen in paraneoplastic cerebellar degeneration. Ann Neurol 56(4):575\u2013579","journal-title":"Ann Neurol"},{"issue":"5","key":"6_CR19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00262-011-0980-z","volume":"60","author":"C Battke","year":"2011","unstructured":"Battke C, Kremmer E, Mysliwietz J, Gondi G, Dumitru C, Brandau S, Lang S, Vullo D, Supuran C, Zeidler R (2011) Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII. Cancer Immunol Immunother 60(5):649\u2013658","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"6_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/ijc.24359","volume":"125","author":"S Bauer","year":"2009","unstructured":"Bauer S, Oosterwijk-Wakka JC, Adrian N, Oosterwijk E, Fischer E, W\u00fcest T, Stenner F, Perani A, Cohen L, Knuth A, Divgi C, J\u00e4ger D, Scott AM, Ritter G, Old LJ, Renner C (2009) Targeted therapy of renal cell carcinoma: synergistic activity of cG250-TNF and IFNg. Int J Cancer 125(1):115\u2013123","journal-title":"Int J Cancer"},{"issue":"Pt 3","key":"6_CR21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1042\/bj3210889","volume":"321","author":"A Bergeron","year":"1997","unstructured":"Bergeron A, LaRue H, Fradet Y (1997) Biochemical analysis of a bladder-cancer-associated mucin: structural features and epitope characterization. Biochem J 321(Pt 3):889\u2013895","journal-title":"Biochem J"},{"issue":"13","key":"6_CR22","doi-asserted-by":"publisher","first-page":"7392","DOI":"10.1021\/acs.jmedchem.0c00636","volume":"63","author":"E Berrino","year":"2020","unstructured":"Berrino E, Angeli A, Zhdanov DD, Kiryukhina AP, Milaneschi A, De Luca A, Bozdag M, Carradori S, Selleri S, Bartolucci G, Peat TS, Ferraroni M, Supuran CT, Carta F (2020) Azidothymidine \u201cClicked\u201d into 1,2,3-Triazoles: first report on carbonic anhydrase-telomerase dual-hybrid inhibitors. J Med Chem 63(13):7392\u20137409","journal-title":"J Med Chem"},{"issue":"5","key":"6_CR23","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/sj.bjc.6601617","volume":"90","author":"I Bleumer","year":"2004","unstructured":"Bleumer I, Knuth A, Oosterwijk E, Hofmann R, Varga Z, Lamers C, Kruit W, Melchior S, Mala C, Ullrich S, De Mulder P, Mulders PF, Beck J (2004) A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients. Br J Cancer 90(5):985\u2013990","journal-title":"Br J Cancer"},{"issue":"1","key":"6_CR24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0022-5347(05)00040-6","volume":"175","author":"I Bleumer","year":"2006","unstructured":"Bleumer I, Oosterwijk E, Oosterwijk-Wakka JC, V\u00f6ller MC, Melchior S, Warnaar SO, Mala C, Beck J, Mulders PF (2006) A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinoma. J Urol 175(1):57\u201362","journal-title":"J Urol"},{"issue":"1","key":"6_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/01.cji.0000211318.22902.ec","volume":"30","author":"I Bleumer","year":"2007","unstructured":"Bleumer I, Tiemessen DM, Oosterwijk-Wakka JC, V\u00f6ller MC, De Weijer K, Mulders PF, Oosterwijk E (2007) Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cells. J Immunother 30(1):116\u2013122","journal-title":"J Immunother"},{"issue":"21","key":"6_CR26","doi-asserted-by":"publisher","first-page":"14655","DOI":"10.1021\/acs.jmedchem.2c01175","volume":"65","author":"L Braconi","year":"2022","unstructured":"Braconi L, Teodori E, Riganti C, Coronnello M, Nocentini A, Bartolucci G, Pallecchi M, Contino M, Manetti D, Romanelli MN, Supuran CT, Dei S (2022) New dual P-glycoprotein (P-gp) and human carbonic anhydrase XII (hCA XII) inhibitors as multidrug resistance (MDR) reversers in cancer cells. J Med Chem 65(21):14655\u201314672","journal-title":"J Med Chem"},{"issue":"14","key":"6_CR27","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.3390\/molecules29143290","volume":"29","author":"L Braconi","year":"2024","unstructured":"Braconi L, Riganti C, Parenti A, Cecchi M, Nocentini A, Bartolucci G, Menicatti M, Contino M, Colabufo NA, Manetti D, Romanelli MN, Supuran CT, Teodori E (2024) Dual inhibitors of P-gp and carbonic anhydrase XII (hCA XII) against tumor multidrug resistance with piperazine scaffold. Molecules 29(14):3290","journal-title":"Molecules"},{"issue":"3","key":"6_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/00006231-200203000-00005","volume":"23","author":"AH Brouwers","year":"2002","unstructured":"Brouwers AH, Dorr U, Lang O, Boerman OC, Oyen WJ, Steffens MG, Oosterwijk E, Mergenthaler HG, Bihl H, Corstens FH (2002) 131 I-cG250 monoclonal antibody immunoscintigraphy versus [18 F]FDG-PET imaging in patients with metastatic renal cell carcinoma: a comparative study. Nucl Med Commun 23(3):229\u2013236","journal-title":"Nucl Med Commun"},{"issue":"10 Pt 2","key":"6_CR29","first-page":"3953S","volume":"9","author":"AH Brouwers","year":"2003","unstructured":"Brouwers AH, Buijs WC, Oosterwijk E, Boerman OC, Mala C, De Mulder PH, Corstens FH, Mulders PF, Oyen WJ (2003) Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with (131)I or (111)in: an intrapatient comparison. Clin Cancer Res 9(10 Pt 2):3953S\u20133960S","journal-title":"Clin Cancer Res"},{"issue":"2","key":"6_CR30","first-page":"155","volume":"19","author":"A Brouwers","year":"2004","unstructured":"Brouwers A, Verel I, Van Eerd J, Visser G, Steffens M, Oosterwijk E, Corstens F, Oyen W, Van Dongen G, Boerman O (2004) PET radioimmunoscintigraphy of renal cell cancer using 89Zr-labeled cG250 monoclonal antibody in nude rats. Cancer Biother Radiopharm 19(2):155\u2013163","journal-title":"Cancer Biother Radiopharm"},{"issue":"19 Pt 2","key":"6_CR31","doi-asserted-by":"publisher","first-page":"7178s","DOI":"10.1158\/1078-0432.CCR-1004-0010","volume":"11","author":"AH Brouwers","year":"2005","unstructured":"Brouwers AH, Buijs WC, Mulders PF, de Mulder PH, van den Broek WJ, Mala C, Oosterwijk E, Boerman OC, Corstens FH, Oyen WJ (2005) Radioimmunotherapy with [131I]cG250 in patients with metastasized renal cell cancer: dosimetric analysis and immunologic response. Clin Cancer Res 11(19 Pt 2):7178s\u20137186s","journal-title":"Clin Cancer Res"},{"issue":"27","key":"6_CR32","doi-asserted-by":"publisher","first-page":"6540","DOI":"10.1200\/JCO.2005.07.732","volume":"23","author":"AH Brouwers","year":"2005","unstructured":"Brouwers AH, Mulders PF, de Mulder PH, van den Broek WJ, Buijs WC, Mala C, Joosten FB, Oosterwijk E, Boerman OC, Corstens FH, Oyen WJ (2005) Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma. J Clin Oncol 23(27):6540\u20136548","journal-title":"J Clin Oncol"},{"key":"6_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2020.102280","volume":"30","author":"N Bug\u00e1rov\u00e1","year":"2020","unstructured":"Bug\u00e1rov\u00e1 N, Annu\u0161ov\u00e1 A, Bod\u00edk M, \u0160iffalovi\u010d P, Labudov\u00e1 M, Kajanov\u00e1 I, Za\u0165ovi\u010dov\u00e1 M, Pastorekov\u00e1 S, Majkov\u00e1 E, Omastov\u00e1 M (2020) Molecular targeting of bioconjugated graphene oxide nanocarriers revealed at a cellular level using label-free Raman imaging. Nanomedicine 30:102280","journal-title":"Nanomedicine"},{"issue":"2","key":"6_CR34","first-page":"802","volume":"9","author":"MH Bui","year":"2003","unstructured":"Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, Stanbridge E, Lerman MI, Palotie A, Figlin RA, Belldegrun AS (2003) Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 9(2):802\u2013811","journal-title":"Clin Cancer Res"},{"issue":"5","key":"6_CR35","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.physbeh.2011.06.013","volume":"104","author":"C Cal\u00f2","year":"2011","unstructured":"Cal\u00f2 C, Padiglia A, Zonza A, Corrias L, Contu P, Tepper BJ, Barbarossa IT (2011) Polymorphisms in TAS2R38 and the taste bud trophic factor, gustin gene co-operate in modulating PROP taste phenotype. Physiol Behav 104(5):1065\u20131071","journal-title":"Physiol Behav"},{"issue":"15","key":"6_CR36","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1158\/1078-0432.CCR-17-3457","volume":"24","author":"S Cazzamalli","year":"2018","unstructured":"Cazzamalli S, Ziffels B, Widmayer F, Murer P, Pellegrini G, Pretto F, Wulhfard S, Neri D (2018) Enhanced therapeutic activity of non-internalizing small-molecule-drug conjugates targeting carbonic anhydrase IX in combination with targeted Interleukin-2. Clin Cancer Res 24(15):3656\u20133667","journal-title":"Clin Cancer Res"},{"issue":"5","key":"6_CR37","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1021\/jacs.7b13361","volume":"140","author":"S Cazzamalli","year":"2018","unstructured":"Cazzamalli S, Dal Corso A, Widmayer F, Neri D (2018) Chemically defined antibody- and small molecule-drug conjugates for in vivo tumor targeting applications: a comparative analysis. J Am Chem Soc 140(5):1617\u20131621","journal-title":"J Am Chem Soc"},{"issue":"15","key":"6_CR38","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1021\/jm0501073","volume":"48","author":"A Cecchi","year":"2005","unstructured":"Cecchi A, Hulikova A, Pastorek J, Pastorekov\u00e1 S, Scozzafava A, Winum JY, Montero JL, Supuran CT (2005) Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors. J Med Chem 48(15):4834\u20134841","journal-title":"J Med Chem"},{"key":"6_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.apradiso.2017.12.013","volume":"133","author":"A \u010cepa","year":"2018","unstructured":"\u010cepa A, R\u00e1li\u0161 J, Kr\u00e1l V, Paurov\u00e1 M, Ku\u010dka J, Humajov\u00e1 J, L\u00e1zn\u00ed\u010dek M, Lebeda O (2018) In vitro evaluation of the monoclonal antibody 64Cu-IgG M75 against human carbonic anhydrase IX and its in vivo imaging. Appl Radiat Isot 133:9\u201313","journal-title":"Appl Radiat Isot"},{"key":"6_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.apradiso.2018.10.021","volume":"143","author":"A \u010cepa","year":"2019","unstructured":"\u010cepa A, R\u00e1li\u0161 J, Mare\u0161ov\u00e1 L, Kleinov\u00e1 M, Seifert D, Sieglov\u00e1 I, Kr\u00e1l V, Pol\u00e1\u0161ek M, Paurov\u00e1 M, L\u00e1zn\u00ed\u010dek M, Lebeda O (2019) Radiolabeling of the antibody IgG M75 for epitope of human carbonic anhydrase IX by 61Cu and 64Cu and its biological testing. Appl Radiat Isot 143:87\u201397","journal-title":"Appl Radiat Isot"},{"issue":"5","key":"6_CR41","doi-asserted-by":"publisher","first-page":"40140","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2(5):40140\u201340144","journal-title":"Cancer Discov"},{"issue":"7","key":"6_CR42","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1158\/2326-6066.CIR-18-0657","volume":"7","author":"SC Chafe","year":"2019","unstructured":"Chafe SC, McDonald PC, Saberi S, Nemirovsky O, Venkateswaran G, Burugu S, Gao D, Delaidelli A, Kyle AH, Baker JHE, Gillespie JA, Bashashati A, Minchinton AI, Zhou Y, Shah SP, Dedhar S (2019) Targeting hypoxia-induced carbonic anhydrase IX enhances immune-checkpoint blockade locally and systemically. Cancer Immunol Res 7(7):1064\u20131078","journal-title":"Cancer Immunol Res"},{"issue":"35","key":"6_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abj0364","volume":"7","author":"SC Chafe","year":"2021","unstructured":"Chafe SC, Vizeacoumar FS, Venkateswaran G, Nemirovsky O, Awrey S, Brown WS, McDonald PC, Carta F, Metcalfe A, Karasinska JM, Huang L, Muthuswamy SK, Schaeffer DF, Renouf DJ, Supuran CT, Vizeacoumar FJ, Dedhar S (2021) Genome-wide synthetic lethal screen unveils novel CAIX-NFS1\/xCT axis as a targetable vulnerability in hypoxic solid tumors. Sci Adv 7(35):eabj0364","journal-title":"Sci Adv"},{"key":"6_CR44","doi-asserted-by":"publisher","first-page":"9981131","DOI":"10.1155\/mi\/9981131","volume":"2024","author":"P Chalova","year":"2024","unstructured":"Chalova P, Jankovicova B, Dvorakova V, Zelinkova E, Bilkova Z, Slovakova M, Korecka L, Muller P, Danchenko M, Minichova L, Lakota J, Skultety L (2024) Inhibitory effect of human anti-CA I autoantibodies and development of monoclonal antibody mAb 2B8 targeting carbonic anhydrase I. Mediat Inflamm 2024:9981131","journal-title":"Mediat Inflamm"},{"issue":"5","key":"6_CR45","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00259-013-2679-1","volume":"41","author":"SM Cheal","year":"2014","unstructured":"Cheal SM, Punzalan B, Doran MG, Evans MJ, Osborne JR, Lewis JS, Zanzonico P, Larson SM (2014) Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcinoma. Eur J Nucl Med Mol Imaging 41(5):985\u2013994","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"6_CR46","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.3892\/ol.2017.6740","volume":"14","author":"J Chen","year":"2017","unstructured":"Chen J, Hu L, Zhang F, Wang J, Chen J, Wang Y (2017) Downregulation of carbonic anhydrase IV contributes to promotion of cell proliferation and is associated with poor prognosis in non-small cell lung cancer. Oncol Lett 14(4):5046\u20135050","journal-title":"Oncol Lett"},{"issue":"12","key":"6_CR47","doi-asserted-by":"publisher","first-page":"12493","DOI":"10.1021\/acs.jmedchem.5c00126","volume":"68","author":"L Chen","year":"2025","unstructured":"Chen L, Chen XM, Mao ZC, Gou Y, Ma XL, Wei JH, Huang RZ, Zhang Y (2025) Discovery of Diaryl Piperidone-sulfonamide as a novel dual-target inhibitor of STAT3\/CAIX inducing Ferroptosis in triple-negative breast cancer cells. J Med Chem 68(12):12493\u201312512","journal-title":"J Med Chem"},{"issue":"7","key":"6_CR48","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/modpathol.2012.57","volume":"25","author":"J Ch\u00eanevert","year":"2012","unstructured":"Ch\u00eanevert J, Duvvuri U, Chiosea S, Dacic S, Cieply K, Kim J, Shiwarski D, Seethala RR (2012) DOG1: a novel marker of salivary acinar and intercalated duct differentiation. Mod Pathol 25(7):919\u2013929","journal-title":"Mod Pathol"},{"issue":"6","key":"6_CR49","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/ijc.11142","volume":"105","author":"A Chrastina","year":"2003","unstructured":"Chrastina A, Z\u00e1vada J, Parkkila S, Kaluz S, Kaluzov\u00e1 M, Rajc\u00e1ni J, Pastorek J, Pastorekov\u00e1 S (2003) Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma. Int J Cancer 105(6):873\u2013881","journal-title":"Int J Cancer"},{"issue":"1","key":"6_CR50","first-page":"13","volume":"50","author":"A Chrastina","year":"2003","unstructured":"Chrastina A, Pastorekov\u00e1 S, Pastorek J (2003) Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody. Neoplasma 50(1):13\u201321","journal-title":"Neoplasma"},{"issue":"3","key":"6_CR51","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3390\/cells9030704","volume":"9","author":"YH Chu","year":"2020","unstructured":"Chu YH, Su CW, Hsieh YS, Chen PN, Lin CW, Yang SF (2020) Carbonic anhydrase III promotes cell migration and epithelial-mesenchymal transition in Oral squamous cell carcinoma. Cells 9(3):704","journal-title":"Cells"},{"key":"6_CR52","volume":"31","author":"KM Chung","year":"2022","unstructured":"Chung KM, Chen YT, Hong CC, Chang IC, Lin SY, Liang LY, Chen YR, Yeh CT, Huang SF (2022) CA10 is associated with HBV-related hepatocarcinogenesis. Biochem Biophys Rep 31:101303","journal-title":"Biochem Biophys Rep"},{"issue":"12","key":"6_CR53","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/mc.20448","volume":"47","author":"HY Dai","year":"2008","unstructured":"Dai HY, Hong CC, Liang SC, Yan MD, Lai GM, Cheng AL, Chuang SE (2008) Carbonic anhydrase III promotes transformation and invasion capability in hepatoma cells through FAK signaling pathway. Mol Carcinog 47(12):956\u2013963","journal-title":"Mol Carcinog"},{"issue":"1","key":"6_CR54","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s13046-018-0992-z","volume":"37","author":"X Dai","year":"2018","unstructured":"Dai X, Yin C, Zhang Y, Guo G, Zhao C, Wang O, Xiang Y, Zhang X, Liang G (2018) Osthole inhibits triple negative breast cancer cells by suppressing STAT3. J Exp Clin Cancer Res 37(1):322","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"6_CR55","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jss.2014.03.042","volume":"190","author":"T Davidov","year":"2014","unstructured":"Davidov T, Nagar M, Kierson M, Chekmareva M, Chen C, Lu SE, Lin Y, Chernyavsky V, Potdevin L, Arumugam D, Barnard N, Trooskin S (2014) Carbonic anhydrase 4 and crystallin \u03b1-B immunoreactivity may distinguish benign from malignant thyroid nodules in patients with indeterminate thyroid cytology. J Surg Res 190(2):565\u2013574","journal-title":"J Surg Res"},{"key":"6_CR56","first-page":"13","volume":"7","author":"ID Davis","year":"2007","unstructured":"Davis ID, Wiseman GA, Lee FT, Gansen DN, Hopkins W, Papenfuss AT, Liu Z, Moynihan TJ, Croghan GA, Adjei AA, Hoffman EW, Ingle JN, Old LJ, Scott AM (2007) A phase I multiple dose, dose escalation study of cG250 monoclonal antibody in patients with advanced renal cell carcinoma. Cancer Immun 7:13","journal-title":"Cancer Immun"},{"issue":"2","key":"6_CR57","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/ijc.33988","volume":"151","author":"E D\u00edaz de la Guardia-Bol\u00edvar","year":"2022","unstructured":"D\u00edaz de la Guardia-Bol\u00edvar E, Barrios-Rodr\u00edguez R, Zwir I, Jim\u00e9nez-Mole\u00f3n JJ, Del Val C (2022) Identification of novel prostate cancer genes in patients stratified by Gleason classification: role of antitumoral genes. Int J Cancer 151(2):255\u2013264","journal-title":"Int J Cancer"},{"issue":"11","key":"6_CR58","first-page":"2729","volume":"4","author":"CR Divgi","year":"1998","unstructured":"Divgi CR, Bander NH, Scott AM, O\u2019Donoghue JA, Sgouros G, Welt S, Finn RD, Morrissey F, Capitelli P, Williams JM, Deland D, Nakhre A, Oosterwijk E, Gulec S, Graham MC, Larson SM, Old LJ (1998) Phase I\/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma. Clin Cancer Res 4(11):2729\u20132739","journal-title":"Clin Cancer Res"},{"issue":"4","key":"6_CR59","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S1470-2045(07)70044-X","volume":"8","author":"CR Divgi","year":"2007","unstructured":"Divgi CR, Pandit-Taskar N, Jungbluth AA, Reuter VE, G\u00f6nen M, Ruan S, Pierre C, Nagel A, Pryma DA, Humm J, Larson SM, Old LJ, Russo P (2007) Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial. Lancet Oncol 8(4):304\u2013310","journal-title":"Lancet Oncol"},{"issue":"2","key":"6_CR60","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1200\/JCO.2011.41.2445","volume":"31","author":"CR Divgi","year":"2013","unstructured":"Divgi CR, Uzzo RG, Gatsonis C, Bartz R, Treutner S, Yu JQ, Chen D, Carrasquillo JA, Larson S, Bevan P, Russo P (2013) Positron emission tomography\/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial. J Clin Oncol 31(2):187\u2013194","journal-title":"J Clin Oncol"},{"key":"6_CR61","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.02523","volume":"3","author":"SJ Dixon","year":"2014","unstructured":"Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, Thomas AG, Gleason CE, Tatonetti NP, Slusher BS, Stockwell BR (2014) Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. elife 3:e02523","journal-title":"elife"},{"issue":"6","key":"6_CR62","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA (2024) The cell biology of ferroptosis. Nat Rev Mol Cell Biol 25(6):424\u2013442","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"6_CR63","doi-asserted-by":"publisher","first-page":"8884","DOI":"10.1021\/acs.jmedchem.1c00629","volume":"64","author":"J Dong","year":"2021","unstructured":"Dong J, Cheng XD, Zhang WD, Qin JJ (2021) Recent update on development of small-molecule STAT3 inhibitors for cancer therapy: from phosphorylation inhibition to protein degradation. J Med Chem 64(13):8884\u20138915","journal-title":"J Med Chem"},{"issue":"5","key":"6_CR64","doi-asserted-by":"publisher","first-page":"739e46","DOI":"10.1007\/s11307-014-0730-7","volume":"16","author":"M Doss","year":"2014","unstructured":"Doss M, Kolb HC, Walsh JC, Mocharla VP, Zhu Z, Haka M et al (2014) Biodistribution and radiation dosimetry of the carbonic anhydrase IX imaging agent [(18) F]VM4-037 determined from PET\/CT scans in healthy volunteers. Mol Imaging Biol 16(5):739e46","journal-title":"Mol Imaging Biol"},{"issue":"3","key":"6_CR65","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.radonc.2011.05.045","volume":"99","author":"L Dubois","year":"2011","unstructured":"Dubois L, Peeters S, Lieuwes NG, Geusens N, Thiry A, Wigfield S, Carta F, McIntyre A, Scozzafava A, Dogn\u00e9 JM, Supuran CT, Harris AL, Masereel B, Lambin P (2011) Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. Radiother Oncol 99(3):424\u2013431","journal-title":"Radiother Oncol"},{"issue":"9","key":"6_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0328305","volume":"20","author":"IH Eissa","year":"2025","unstructured":"Eissa IH, Elkady H, Elgammal WE, Mahdy HA, Husein DZ, Amin FG, Elsheshiny AAA, Abdelfattah SS, Alsfouk AA, Elkaeed EB, Metwaly AM (2025) A novel sulfamoylphenyl-dihydro-thiadiazole derivative as a dual EGFR and carbonic anhydrase inhibitor for cancer therapy. PLoS One 20(9):e0328305","journal-title":"PLoS One"},{"issue":"Pt 2","key":"6_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.135010","volume":"279","author":"WM Eldehna","year":"2024","unstructured":"Eldehna WM, Elsayed ZM, Ammara A, El Hassab MA, Almahli H, Fares M, Nocentini A, Supuran CT, Abou-Seri SM (2024) Discovery of new sulfonamide-tethered 2-aryl-4-anilinoquinazolines as the first-in-class dual carbonic anhydrase and EGFR inhibitors. Int J Biol Macromol 279(Pt 2):135010","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"6_CR68","first-page":"3183","volume":"46","author":"AA Epenetos","year":"1986","unstructured":"Epenetos AA, Snook D, Durbin H, Johnson PM, Taylor-Papadimitriou J (1986) Limitations of radiolabeled monoclonal antibodies for localization of human neoplasms. Cancer Res 46(6):3183\u20133191","journal-title":"Cancer Res"},{"issue":"5","key":"6_CR69","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.semcancer.2008.03.011","volume":"18","author":"JS Fang","year":"2008","unstructured":"Fang JS, Gillies RD, Gatenby RA (2008) Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression. Semin Cancer Biol 18(5):330\u2013337","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"6_CR70","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s40618-023-02008-4","volume":"46","author":"L Fei","year":"2023","unstructured":"Fei L, Cantini G, Nocentini A, Nardini P, Catarinicchia S, Canu L, Ercolino T, Quartararo G, Nesi G, Gacci M, Maggi M, Hantel C, Mannelli M, Supuran CT, Luconi M (2023) Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment. J Endocrinol Investig 46(7):1449\u20131458","journal-title":"J Endocrinol Investig"},{"issue":"6_suppl","key":"6_CR71","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.6_suppl.TPS752","volume":"41","author":"DR Feldman","year":"2023","unstructured":"Feldman DR, Motzer RJ, Knezevic A, Lee CH, Voss MH, Lyashchenko SK, Park H, Larson SM, Pandit-Taskar N (2023) STARLITE 2: phase 2 study of nivolumab plus177 Lutetium-labeled anti\u2013carbonic anhydrase IX (CAIX) monoclonal antibody girentuximab (177 Lu-Girentuximab) in patients (Pts) with advanced clear cell renal cell carcinoma (ccRCC). J Clin Oncol 41(6_suppl):TPS752","journal-title":"J Clin Oncol"},{"issue":"12","key":"6_CR72","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/cmdc.201800130","volume":"13","author":"L Fiedler","year":"2018","unstructured":"Fiedler L, Kellner M, Oos R, B\u00f6ning G, Ziegler S, Bartenstein P, Zeidler R, Gildehaus FJ, Lindner S (2018) Fully automated production and characterization of 64 Cu and proof-of-principle small-animal PET imaging using 64 Cu-labelled CA XII targeting 6A10 fab. ChemMedChem 13(12):1230\u20131237","journal-title":"ChemMedChem"},{"key":"6_CR73","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.nucmedbio.2018.02.004","volume":"60","author":"L Fiedler","year":"2018","unstructured":"Fiedler L, Kellner M, Gosewisch A, Oos R, B\u00f6ning G, Lindner S, Albert N, Bartenstein P, Reulen HJ, Zeidler R, Gildehaus FJ (2018) Evaluation of 177Lu[Lu]-CHX-A\u2033-DTPA-6A10 fab as a radioimmunotherapy agent targeting carbonic anhydrase XII. Nucl Med Biol 60:55\u201362","journal-title":"Nucl Med Biol"},{"issue":"13","key":"6_CR74","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1002\/anie.201410736","volume":"54","author":"RM Franzini","year":"2015","unstructured":"Franzini RM, Ekblad T, Zhong N, Wichert M, Decurtins W, Nauer A, Zimmermann M, Samain F, Scheuermann J, Brown PJ, Hall J, Gr\u00e4slund S, Sch\u00fcler H, Neri D (2015) Identification of structure-activity relationships from screening a structurally compact DNA-encoded chemical library. Angew Chem Int Ed Engl 54(13):3927\u20133931","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"6_CR75","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41392-022-00947-7","volume":"7","author":"Z Fu","year":"2022","unstructured":"Fu Z, Li S, Han S, Shi C, Zhang Y (2022) Antibody drug conjugate: the \u201cbiological missile\u201d for targeted cancer therapy. Signal Transduct Target Ther 7(1):93","journal-title":"Signal Transduct Target Ther"},{"issue":"269","key":"6_CR76","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6(269):pl1","journal-title":"Sci Signal"},{"issue":"2","key":"6_CR77","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5009\/gnl17163","volume":"12","author":"HL Gao","year":"2018","unstructured":"Gao HL, Wang X, Sun HR, Zhou JD, Lin SQ, Xing YH, Zhu L, Zhou HB, Zhao YS, Chi Q, Liu YP (2018) Methylation status of transcriptional modulatory genes associated with colorectal cancer in Northeast China. Gut Liver 12(2):173\u2013182","journal-title":"Gut Liver"},{"issue":"7","key":"6_CR78","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1007\/s10571-023-01388-8","volume":"43","author":"X Gao","year":"2023","unstructured":"Gao X, Hu W, Qian D, Bai X, He H, Li L, Sun S (2023) The mechanisms of Ferroptosis under hypoxia. Cell Mol Neurobiol 43(7):3329\u20133341","journal-title":"Cell Mol Neurobiol"},{"issue":"11","key":"6_CR79","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4(11):891\u2013899","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"6_CR80","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nrc2255","volume":"8","author":"RA Gatenby","year":"2008","unstructured":"Gatenby RA, Gillies RJ (2008) A microenvironmental model of carcinogenesis. Nat Rev Cancer 8(1):56\u201361","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"6_CR81","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1186\/s12885-020-07183-8","volume":"20","author":"A Ge","year":"2020","unstructured":"Ge A, Gao S, Liu Y, Zhang H, Wang X, Zhang L, Pang D, Zhao Y (2020) Methylation of WT1, CA10 in peripheral blood leukocyte is associated with breast cancer risk: a case-control study. BMC Cancer 20(1):713","journal-title":"BMC Cancer"},{"issue":"21","key":"6_CR82","doi-asserted-by":"publisher","first-page":"6494","DOI":"10.1158\/0008-5472.CAN-13-1110","volume":"73","author":"G Gondi","year":"2013","unstructured":"Gondi G, Mysliwietz J, Hulikova A, Jen JP, Swietach P, Kremmer E, Zeidler R (2013) Antitumor efficacy of a monoclonal antibody that inhibits the activity of cancer-associated carbonic anhydrase XII. Cancer Res 73(21):6494\u20136503","journal-title":"Cancer Res"},{"issue":"1","key":"6_CR83","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.bmcl.2011.10.058","volume":"22","author":"K Groves","year":"2012","unstructured":"Groves K, Bao B, Zhang J, Handy E, Kennedy P, Cuneo G, Supuran CT, Yared W, Peterson JD, Rajopadhye M (2012) Synthesis and evaluation of near-infrared fluorescent sulfonamide derivatives for imaging of hypoxia-induced carbonic anhydrase IX expression in tumors. Bioorg Med Chem Lett 22(1):653\u2013657","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"6_CR84","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/CCO.0b013e32835b651e","volume":"25","author":"P Hainaut","year":"2013","unstructured":"Hainaut P, Plymoth A (2013) Targeting the hallmarks of cancer: towards a rational approach to next-generation cancer therapy. Curr Opin Oncol 25(1):50\u201351","journal-title":"Curr Opin Oncol"},{"issue":"5","key":"6_CR85","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674","journal-title":"Cell"},{"issue":"9","key":"6_CR86","doi-asserted-by":"publisher","first-page":"7406","DOI":"10.1021\/acs.jmedchem.4c00239","volume":"67","author":"SM Hefny","year":"2024","unstructured":"Hefny SM, El-Moselhy TF, El-Din N, Giovannuzzi S, Bin Traiki T, Vaali-Mohammed MA, El-Dessouki AM, Yamaguchi K, Sugiura M, Shaldam MA, Supuran CT, Abdulla MH, Eldehna WM, Tawfik HO (2024) Discovery and mechanistic studies of dual-target hits for carbonic anhydrase IX and VEGFR-2 as potential agents for solid tumors: X-ray, in vitro, in vivo, and in Silico investigations of Coumarin-based Thiazoles. J Med Chem 67(9):7406\u20137430","journal-title":"J Med Chem"},{"issue":"3","key":"6_CR87","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.eururo.2018.04.026","volume":"74","author":"MCH Hekman","year":"2018","unstructured":"Hekman MCH, Rijpkema M, Aarntzen EH, Mulder SF, Langenhuijsen JF, Oosterwijk E, Boerman OC, Oyen WJG, Mulders PFA (2018) Positron emission tomography\/computed tomography with 89Zr-girentuximab can aid in diagnostic dilemmas of clear cell renal cell carcinoma suspicion. Eur Urol 74(3):257\u2013260","journal-title":"Eur Urol"},{"issue":"8","key":"6_CR88","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.7150\/thno.23335","volume":"8","author":"MC Hekman","year":"2018","unstructured":"Hekman MC, Rijpkema M, Muselaers CH, Oosterwijk E, Hulsbergen-Van de Kaa CA, Boerman OC, Oyen WJ, Langenhuijsen JF, Mulders PF (2018) Tumor-targeted dual-modality imaging to improve intraoperative visualization of clear cell renal cell carcinoma: a first in man study. Theranostics 8(8):2161\u20132170","journal-title":"Theranostics"},{"issue":"41","key":"6_CR89","doi-asserted-by":"publisher","first-page":"27799","DOI":"10.1074\/jbc.M800938200","volume":"283","author":"M Hilvo","year":"2008","unstructured":"Hilvo M, Baranauskiene L, Salzano AM, Scaloni A, Matulis D, Innocenti A, Scozzafava A, Monti SM, Di Fiore A, De Simone G, Lindfors M, J\u00e4nis J, Valjakka J, Pastorekov\u00e1 S, Pastorek J, Kulomaa MS, Nordlund HR, Supuran CT, Parkkila S (2008) Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes. J Biol Chem 283(41):27799\u201327809","journal-title":"J Biol Chem"},{"issue":"5","key":"6_CR90","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/his.12792","volume":"68","author":"MS Hsieh","year":"2016","unstructured":"Hsieh MS, Jeng YM, Jhuang YL, Chou YH, Lin CY (2016) Carbonic anhydrase VI: a novel marker for salivary serous acinar differentiation and its application to discriminate acinic cell carcinoma from mammary analogue secretory carcinoma of the salivary gland. Histopathology 68(5):641\u2013647","journal-title":"Histopathology"},{"issue":"5","key":"6_CR91","first-page":"1030","volume":"10","author":"M Hsieh","year":"2022","unstructured":"Hsieh M, Huang PJ, Chou PY, Wang SW, Lu HC, Su WW, Chung YC, Wu MH (2022) Carbonic anhydrase VIII (CAVIII) gene mediated colorectal cancer growth and angiogenesis through mediated miRNA 16-5p. Biomedicine 10(5):1030","journal-title":"Biomedicine"},{"key":"6_CR92","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcancer.2017.06.001","volume":"45","author":"J Huynh","year":"2017","unstructured":"Huynh J, Etemadi N, Hollande F, Ernst M, Buchert M (2017) The JAK\/STAT3 axis: a comprehensive drug target for solid malignancies. Semin Cancer Biol 45:13\u201322","journal-title":"Semin Cancer Biol"},{"issue":"20","key":"6_CR93","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.1016\/j.bmcl.2009.08.088","volume":"19","author":"A Innocenti","year":"2009","unstructured":"Innocenti A, Pastorekova S, Pastorek J, Scozzafava A, De Simone G, Supuran CT (2009) The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as anintrinsic buffer optimizing CO2 hydration at acidic pH values characteristic of solid tumors. Bioorg Med Chem Lett 19(20):5825\u20135828","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"6_CR94","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1007\/s00428-006-0199-0","volume":"448","author":"T Ishihara","year":"2006","unstructured":"Ishihara T, Takeuchi T, Nishimori I, Adachi Y, Minakuchi T, Fujita J, Sonobe H, Ohtsuki Y, Onishi S (2006) Carbonic anhydrase-related protein VIII increases invasiveness of non-small cell lung adenocarcinoma. Virchows Arch 448(6):830\u2013837","journal-title":"Virchows Arch"},{"issue":"11","key":"6_CR95","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.4252\/wjsc.v12.i11.1410","volume":"12","author":"P Jagust","year":"2020","unstructured":"Jagust P, Alcal\u00e1 S, Sainz B Jr, Heeschen C, Sancho P (2020) Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells. World J Stem Cells 12(11):1410\u20131428","journal-title":"World J Stem Cells"},{"key":"6_CR96","doi-asserted-by":"publisher","first-page":"11604","DOI":"10.1073\/pnas.121172598","volume":"98","author":"P Karhumaa","year":"2001","unstructured":"Karhumaa P, Leinonen J, Parkkila S, Kaunisto K, Tapanainen J, Rajaniemi H (2001) The identification of secreted carbonic anhydrase VI as a constitutive glycoprotein of human and rat milk. Proc Natl Acad Sci USA 98:11604\u201311608","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"6_CR97","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2214\/AJR.14.12490","volume":"203","author":"AH Khandani","year":"2014","unstructured":"Khandani AH, Rathmell WK, Wallen EM, Ivanovic M (2014) PET\/CT with (124)I-cG250: great potential and some open questions. AJR Am J Roentgenol 203(2):261\u2013262","journal-title":"AJR Am J Roentgenol"},{"issue":"27","key":"6_CR98","doi-asserted-by":"publisher","first-page":"11154","DOI":"10.1073\/pnas.0901591106","volume":"106","author":"MK Kim","year":"2009","unstructured":"Kim MK, McGarry TJ, O Broin P, Flatow JM, Golden AA, Licht JD (2009) An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1. Proc Natl Acad Sci USA 106(27):11154\u201311159","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"6_CR99","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2304081120","volume":"120","author":"JH Kim","year":"2023","unstructured":"Kim JH, Park S, Jung E, Shin J, Kim YJ, Kim JY, Sessler JL, Seo JH, Kim JS (2023) A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasis. Proc Natl Acad Sci USA 120(21):e2304081120","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 2","key":"6_CR100","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1469-7793.1999.t01-1-00315.x","volume":"520","author":"J Kivela","year":"1999","unstructured":"Kivela J, Parkkila S, Parkkila AK, Leinonen J, Rajaniemi H (1999) Salivary carbonic anhydrase isoenzyme VI. J Physiol 520(Pt 2):315\u2013320","journal-title":"J Physiol"},{"issue":"10","key":"6_CR101","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1023\/A:1011910931210","volume":"46","author":"AJ Kivela","year":"2001","unstructured":"Kivela AJ, Saarnio J, Karttunen TJ, Kivel\u00e4 J, Parkkila AK, Pastorekova S, Pastorek J, Waheed A, Sly WS, Parkkila TS, Rajaniemi H (2001) Differential expression of cytoplasmic carbonic anhydrases, CA I and II, and membrane-associated isozymes, CA IX and XII, in normal mucosa of large intestine and in colorectal tumors. Dig Dis Sci 46(10):2179\u20132186","journal-title":"Dig Dis Sci"},{"issue":"9","key":"6_CR102","doi-asserted-by":"publisher","first-page":"6776","DOI":"10.18632\/oncotarget.2882","volume":"6","author":"J Kopecka","year":"2015","unstructured":"Kopecka J, Campia I, Jacobs A, Frei AP, Ghigo D, Wollscheid B, Riganti C (2015) Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells. Oncotarget 6(9):6776\u20136793","journal-title":"Oncotarget"},{"issue":"3","key":"6_CR103","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/prot.21821","volume":"71","author":"V Kr\u00e1l","year":"2008","unstructured":"Kr\u00e1l V, Mader P, Collard R, F\u00e1bry M, Horejs\u00ed M, Rez\u00e1cov\u00e1 P, Koz\u00edsek M, Z\u00e1vada J, Sedl\u00e1cek J, Rul\u00edsek L, Brynda J (2008) Stabilization of antibody structure upon association to a human carbonic anhydrase IX epitope studied by X-ray crystallography, microcalorimetry, and molecular dynamics simulations. Proteins 71(3):1275\u20131287","journal-title":"Proteins"},{"issue":"16","key":"6_CR104","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1002\/anie.201310709","volume":"53","author":"N Krall","year":"2014","unstructured":"Krall N, Pretto F, Decurtins W, Bernardes GJ, Supuran CT, Neri D (2014) A small-molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors. Angew Chem Int Ed Engl 53(16):4231\u20134235","journal-title":"Angew Chem Int Ed Engl"},{"issue":"6","key":"6_CR105","doi-asserted-by":"publisher","first-page":"943","DOI":"10.2967\/jnumed.115.170514","volume":"57","author":"N Krall","year":"2016","unstructured":"Krall N, Pretto F, Mattarella M, M\u00fcller C, Neri D (2016) A 99mTc-labeled ligand of carbonic anhydrase IX selectively targets renal cell carcinoma in vivo. J Nucl Med 57(6):943\u2013949","journal-title":"J Nucl Med"},{"issue":"1","key":"6_CR106","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1080\/14756366.2020.1734800","volume":"35","author":"M Krasavin","year":"2020","unstructured":"Krasavin M, Sharonova T, Sharoyko V, Zhukovsky D, Kalinin S, \u017dalubovskis R, Tennikova T, Supuran CT (2020) Combining carbonic anhydrase and thioredoxin reductase inhibitory motifs within a single molecule dramatically increases its cytotoxicity. J Enzyme Inhib Med Chem 35(1):665\u2013671","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"1","key":"6_CR107","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1080\/14756366.2020.1712596","volume":"35","author":"M Krasavin","year":"2020","unstructured":"Krasavin M, \u017dalubovskis R, Grand\u0101ne A, Domra\u010deva I, Zhmurov P, Supuran CT (2020) Sulfocoumarins as dual inhibitors of human carbonic anhydrase isoforms IX\/XII and of human thioredoxin reductase. J Enzyme Inhib Med Chem 35(1):506\u2013510","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"6","key":"6_CR108","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer G, Pouyssegur J (2008) Tumor cell metabolism: cancer\u2019s Achilles\u2019 heel. Cancer Cell 13(6):472\u2013482","journal-title":"Cancer Cell"},{"key":"6_CR109","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2407-5-41","volume":"5","author":"L Kummola","year":"2005","unstructured":"Kummola L, H\u00e4m\u00e4l\u00e4inen JM, Kivel\u00e4 J, Kivel\u00e4 AJ, Saarnio J, Karttunen T, Parkkila S (2005) Expression of a novel carbonic anhydrase, CA XIII, in normal and neoplastic colorectal mucosa. BMC Cancer 5:41","journal-title":"BMC Cancer"},{"issue":"3","key":"6_CR110","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/jcmm.13000","volume":"21","author":"J Lakota","year":"2017","unstructured":"Lakota J, Vulic R, Dubrovcakova M, Tyciakova S (2017) Sera of patients with spontaneous tumour regression and elevated anti-CA I autoantibodies change the gene expression of ECM proteins. J Cell Mol Med 21(3):543\u2013551","journal-title":"J Cell Mol Med"},{"issue":"22","key":"6_CR111","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1111\/jcmm.17970","volume":"27","author":"J Lakota","year":"2023","unstructured":"Lakota J (2023) Spontaneous regression of tumours. Possible cross reactivity of autoantibodies against carbonic anhydrase I. J Cell Mol Med 27(22):3637\u20133640","journal-title":"J Cell Mol Med"},{"issue":"3","key":"6_CR112","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1021\/acs.molpharmaceut.5b00934","volume":"13","author":"J Lau","year":"2016","unstructured":"Lau J, Zhang Z, Jenni S, Kuo HT, Liu Z, Vullo D, Supuran CT, Lin KS, B\u00e9nard F (2016) PET imaging of carbonic anhydrase IX expression of HT-29 tumor xenograft mice with (68)Ga-labeled Benzenesulfonamides. Mol Pharm 13(3):1137\u20131146","journal-title":"Mol Pharm"},{"issue":"17","key":"6_CR113","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.7150\/thno.21848","volume":"7","author":"J Lau","year":"2017","unstructured":"Lau J, Lin KS, B\u00e9nard F (2017) Past, present, and future: development of theranostic agents targeting carbonic anhydrase IX. Theranostics 7(17):4322\u20134339","journal-title":"Theranostics"},{"issue":"7","key":"6_CR114","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/0883-2889(88)90056-1","volume":"39","author":"D Le Bars","year":"1988","unstructured":"Le Bars D, Luthra SK, Pike VW, Swenson ER (1988) The radiosynthesis of a 11C- labelled carbonic anhydrase inhibitor\u2014[carbonyl-11C]acetazolamide. Int J Radiat Appl Instrum Part A 39(7):671\u2013675","journal-title":"Int J Radiat Appl Instrum Part A"},{"issue":"10","key":"6_CR115","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s12272-019-01185-2","volume":"42","author":"MT Lebelo","year":"2019","unstructured":"Lebelo MT, Joubert AM, Visagie MH (2019) Warburg effect and its role in tumourigenesis. Arch Pharm Res 42(10):833\u2013847","journal-title":"Arch Pharm Res"},{"issue":"1","key":"6_CR116","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13058-023-01644-1","volume":"25","author":"S Lee","year":"2023","unstructured":"Lee S, Toft NJ, Axelsen TV, Espejo MS, Pedersen TM, Mele M, Pedersen HL, Balling E, Johansen T, Burton M, Thomassen M, Vahl P, Christiansen P, Boedtkjer E (2023) Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2\/HER2-enriched breast cancer. Breast Cancer Res 25(1):46","journal-title":"Breast Cancer Res"},{"issue":"8","key":"6_CR117","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1369\/jhc.4A6282.2004","volume":"52","author":"JS Leinonen","year":"2004","unstructured":"Leinonen JS, Saari KA, Sepp\u00e4nen JM, Myllyl\u00e4 HM, Rajaniemi HJ (2004) Immunohistochemical demonstration of carbonic anhydrase isoenzyme VI (CA VI) expression in rat lower airways and lung. J Histochem Cytochem 52(8):1107\u20131112","journal-title":"J Histochem Cytochem"},{"issue":"4","key":"6_CR118","doi-asserted-by":"publisher","first-page":"168.e1","DOI":"10.1016\/j.urolonc.2021.09.020","volume":"40","author":"Q Li","year":"2022","unstructured":"Li Q, Zhang L, Zhang Z, Fan Y, Zhang Q (2022) Carbonic anhydrase 10 functions as a tumor suppressor in renal cell carcinoma and its methylation is a risk factor for survival outcome. Urol Oncol 40(4):168.e1\u2013168.e9","journal-title":"Urol Oncol"},{"key":"6_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101297","volume":"26","author":"Z Li","year":"2019","unstructured":"Li Z, Jiang L, Chew SH, Hirayama T, Sekido Y, Toyokuni S (2019) Carbonic anhydrase 9 confers resistance to ferroptosis\/apoptosis in malignant mesothelioma under hypoxia. Redox Biol 26:101297","journal-title":"Redox Biol"},{"issue":"7","key":"6_CR120","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1600-0714.2012.01135.x","volume":"41","author":"CM Liu","year":"2012","unstructured":"Liu CM, Lin YM, Yeh KT, Chen MK, Chang JH, Chen CJ, Chou MY, Yang SF, Chien MH (2012) Expression of carbonic anhydrases I\/II and the correlation to clinical aspects of oral squamous cell carcinoma analyzed using tissue microarray. J Oral Pathol Med 41(7):533\u2013539","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"6_CR121","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00262-002-0268-4","volume":"51","author":"Z Liu","year":"2002","unstructured":"Liu Z, Smyth FE, Renner C, Lee FT, Oosterwijk E, Scott AM (2002) Anti-renal cell carcinoma chimeric antibody G250: cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity. Cancer Immunol Immunother 51(3):171\u2013177","journal-title":"Cancer Immunol Immunother"},{"key":"6_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111328","volume":"122","author":"XQ Liu","year":"2024","unstructured":"Liu XQ, Shi MZ, Bai YT, Su XL, Liu YM, Wu JC, Chen LR (2024) Hypoxia and ferroptosis. Cell Signal 122:111328","journal-title":"Cell Signal"},{"issue":"1","key":"6_CR123","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrclinonc.2016.96","volume":"14","author":"JS Lopez","year":"2017","unstructured":"Lopez JS, Banerji U (2017) Combine and conquer: challenges for targeted therapy combinations in early phase trials. Nat Rev Clin Oncol 14(1):57\u201366","journal-title":"Nat Rev Clin Oncol"},{"issue":"19","key":"6_CR124","first-page":"329","volume":"120","author":"F Lordick","year":"2023","unstructured":"Lordick F, Merz M, B\u00fcch E, Aigner A (2023) Antibody-drug conjugates as a targeted therapeutic approach across entities in oncology. Dtsch Arztebl Int 120(19):329\u2013336","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"6_CR125","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.lungcan.2003.12.011","volume":"44","author":"SH Lu","year":"2004","unstructured":"Lu SH, Takeuchi T, Fujita J, Ishida T, Akisawa Y, Nishimori I, Kohsaki T, Onishi S, Sonobe H, Ohtsuki Y (2004) Effect of carbonic anhydrase-related protein VIII expression on lung adenocarcinoma cell growth. Lung Cancer 44(3):273\u2013280","journal-title":"Lung Cancer"},{"issue":"2","key":"6_CR126","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1021\/jm3015348","volume":"56","author":"G Lu","year":"2013","unstructured":"Lu G, Hillier SM, Maresca KP, Zimmerman CN, Eckelman WC, Joyal JL, Babich JW (2013) Synthesis and SAR of novel Re\/99mTc-labeled benzenesulfonamide carbonic anhydrase IX inhibitors for molecular imaging of tumor hypoxia. J Med Chem 56(2):510\u2013520","journal-title":"J Med Chem"},{"key":"6_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109578","volume":"121","author":"HL Ma","year":"2020","unstructured":"Ma HL, Yu SJ, Chen J, Ding XF, Chen G, Liang Y, Pan JL (2020) CA8 promotes RCC proliferation and migration though its expression level is lower in tumor compared to adjacent normal tissue. Biomed Pharmacother 121:109578","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"6_CR128","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12964-020-0527-z","volume":"18","author":"JH Ma","year":"2020","unstructured":"Ma JH, Qin L, Li X (2020) Role of STAT3 signaling pathway in breast cancer. Cell Commun Signal 18(1):33","journal-title":"Cell Commun Signal"},{"key":"6_CR129","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.2147\/DDDT.S257494","volume":"14","author":"XH Makhoba","year":"2020","unstructured":"Makhoba XH, Viegas C Jr, Mosa RA, Viegas FPD, Pooe OJ (2020) Potential impact of the multi-target drug approach in the treatment of some complex diseases. Drug Des Devel Ther 14:3235\u20133249","journal-title":"Drug Des Devel Ther"},{"issue":"22","key":"6_CR130","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1158\/0008-5472.CAN-20-1232","volume":"80","author":"M Mamo","year":"2020","unstructured":"Mamo M, Ye IC, DiGiacomo JW, Park JY, Downs B, Gilkes DM (2020) Hypoxia alters the response to anti-EGFR therapy by regulating EGFR expression and downstream signaling in a DNA methylation-specific and HIF-dependent manner. Cancer Res 80(22):4998\u20135010","journal-title":"Cancer Res"},{"issue":"1","key":"6_CR131","doi-asserted-by":"publisher","first-page":"18661","DOI":"10.1038\/s41598-025-01986-0","volume":"15","author":"J Mao","year":"2025","unstructured":"Mao J, Cai Z, Xie D, Guo M, Gao Y, Zhao G, Zhou J (2025) CA3 bridges dietary restriction to glioblastoma suppression and tumor progression as a key downstream effector. Sci Rep 15(1):18661","journal-title":"Sci Rep"},{"issue":"6","key":"6_CR132","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1021\/acs.molpharmaceut.8b00139","volume":"15","author":"IS Marks","year":"2018","unstructured":"Marks IS, Gardeen SS, Kurdziel SJ, Nicolaou ST, Woods JE, Kularatne SA, Low PS (2018) Development of a small molecule Tubulysin B conjugate for treatment of carbonic anhydrase IX receptor expressing cancers. Mol Pharm 15(6):2289\u20132296","journal-title":"Mol Pharm"},{"issue":"5","key":"6_CR133","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S1097-2765(01)00242-8","volume":"7","author":"SI Matsuzawa","year":"2001","unstructured":"Matsuzawa SI, Reed JC (2001) Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol Cell 7(5):915\u2013926","journal-title":"Mol Cell"},{"issue":"10","key":"6_CR134","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3390\/genes14101836","volume":"14","author":"NS Maurya","year":"2023","unstructured":"Maurya NS, Kushwaha S, Vetukuri RR, Mani A (2023) Unlocking the potential of the CA2, CA7, and ITM2C gene signatures for the early detection of colorectal cancer: a comprehensive analysis of RNA-Seq data by utilizing machine learning algorithms. Genes (Basel) 14(10):1836","journal-title":"Genes (Basel)"},{"issue":"6733","key":"6_CR135","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399(6733):271\u2013275","journal-title":"Nature"},{"issue":"1","key":"6_CR136","first-page":"19","volume":"8","author":"MY Mboge","year":"2018","unstructured":"Mboge MY, Mahon BP, McKenna R, Frost SC (2018) Carbonic anhydrases: role in pH control and cancer. Meta 8(1):19","journal-title":"Meta"},{"issue":"3","key":"6_CR137","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1053\/j.gastro.2019.05.004","volume":"157","author":"PC McDonald","year":"2019","unstructured":"McDonald PC, Chafe SC, Brown WS, Saberi S, Swayampakula M, Venkateswaran G, Nemirovsky O, Gillespie JA, Karasinska JM, Kalloger SE, Supuran CT, Schaeffer DF, Bashashati A, Shah SP, Topham JT, Yapp DT, Li J, Renouf DJ, Stanger BZ, Dedhar S (2019) Regulation of pH by carbonic anhydrase 9 mediates survival of pancreatic cancer cells with activated KRAS in response to hypoxia. Gastroenterology 157(3):823\u2013837","journal-title":"Gastroenterology"},{"key":"6_CR138","doi-asserted-by":"publisher","first-page":"1327310","DOI":"10.3389\/fmolb.2023.1327310","volume":"10","author":"PC McDonald","year":"2023","unstructured":"McDonald PC, Dedhar S (2023) Co-vulnerabilities of inhibiting carbonic anhydrase IX in ferroptosis-mediated tumor cell death. Front Mol Biosci 10:1327310","journal-title":"Front Mol Biosci"},{"key":"6_CR139","doi-asserted-by":"crossref","unstructured":"Mendler CT, Gehring T, Wester HJ, Schwaiger M, Skerra A (2015) 89Zr-labeled versus 124I-labeled \u03b1HER2 fab with optimized plasma half-life for high-contrast tumor imaging in vivo. J Nucl Med 56(7):1112\u20131118","DOI":"10.2967\/jnumed.114.149690"},{"issue":"10","key":"6_CR140","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1007\/s00259-021-05271-w","volume":"48","author":"RIJ Merkx","year":"2021","unstructured":"Merkx RIJ, Lobeek D, Konijnenberg M, Jim\u00e9nez-Franco LD, Kluge A, Oosterwijk E, Mulders PFA, Rijpkema M (2021) Phase I study to assess safety, biodistribution and radiation dosimetry for 89Zr-girentuximab in patients with renal cell carcinoma. Eur J Nucl Med Mol Imaging 48(10):3277\u20133285","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"35","key":"6_CR141","doi-asserted-by":"publisher","first-page":"56471e9","DOI":"10.18632\/oncotarget.10602","volume":"7","author":"I Minn","year":"2016","unstructured":"Minn I, Koo SM, Lee HS, Brummet M, Rowe SP, Gorin MA et al (2016) [64Cu]XYIMSR-06: a dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma. Oncotarget 7(35):56471e9","journal-title":"Oncotarget"},{"issue":"1","key":"6_CR142","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/path.1404","volume":"201","author":"E Miyaji","year":"2003","unstructured":"Miyaji E, Nishimori I, Taniuchi K, Takeuchi T, Ohtsuki Y, Onishi S (2003) Overexpression of carbonic anhydrase-related protein VIII in human colorectal cancer. J Pathol 201(1):37\u201345","journal-title":"J Pathol"},{"issue":"6","key":"6_CR143","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1002\/med.21713","volume":"40","author":"CB Mishra","year":"2020","unstructured":"Mishra CB, Tiwari M, Supuran CT (2020) Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: where are we today? Med Res Rev 40(6):2485\u20132565","journal-title":"Med Res Rev"},{"issue":"1","key":"6_CR144","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14756366.2016.1225046","volume":"32","author":"DM Monti","year":"2017","unstructured":"Monti DM, De Simone G, Langella E, Supuran CT, Di Fiore A, Monti SM (2017) Insights into the role of reactive sulfhydryl groups of carbonic anhydrase III and VII during oxidative damage. J Enzyme Inhib Med Chem 32(1):5\u201312","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"9","key":"6_CR145","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1039\/D3SC06365H","volume":"15","author":"KA Morgan","year":"2024","unstructured":"Morgan KA, Wichmann CW, Osellame LD, Cao Z, Guo N, Scott AM, Donnelly PS (2024) Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX. Chem Sci 15(9):3372\u20133381","journal-title":"Chem Sci"},{"issue":"3","key":"6_CR146","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/0016-5085(93)90900-W","volume":"105","author":"M Mori","year":"1993","unstructured":"Mori M, Staniunas RJ, Barnard GF, Jessup JM, Steele GD Jr, Chen LB (1993) The significance of carbonic anhydrase expression in human colorectal cancer. Gastroenterology 105(3):820\u2013826","journal-title":"Gastroenterology"},{"issue":"1","key":"6_CR147","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00428-005-1225-3","volume":"447","author":"K Morimoto","year":"2005","unstructured":"Morimoto K, Nishimori I, Takeuchi T, Kohsaki T, Okamoto N, Taguchi T, Yunoki S, Watanabe R, Ohtsuki Y, Onishi S (2005) Overexpression of carbonic anhydrase-related protein XI promotes proliferation and invasion of gastrointestinal stromal tumors. Virchows Arch 447(1):66\u201373","journal-title":"Virchows Arch"},{"issue":"6","key":"6_CR148","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.eururo.2013.02.022","volume":"63","author":"CH Muselaers","year":"2013","unstructured":"Muselaers CH, Boerman OC, Oosterwijk E, Langenhuijsen JF, Oyen WJ, Mulders PF (2013) Indium-111-labeled girentuximab immunoSPECT as a diagnostic tool in clear cell renal cell carcinoma. Eur Urol 63(6):1101\u20131106","journal-title":"Eur Urol"},{"issue":"5","key":"6_CR149","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.eururo.2015.11.033","volume":"69","author":"CH Muselaers","year":"2016","unstructured":"Muselaers CH, Boers-Sonderen MJ, van Oostenbrugge TJ, Boerman OC, Desar IM, Stillebroer AB, Mulder SF, van Herpen CM, Langenhuijsen JF, Oosterwijk E, Oyen WJ, Mulders PF (2016) Phase 2 study of lutetium 177-labeled anti-carbonic anhydrase IX monoclonal antibody Girentuximab in patients with advanced renal cell carcinoma. Eur Urol 69(5):767\u2013770","journal-title":"Eur Urol"},{"key":"6_CR150","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.biocel.2018.12.017","volume":"107","author":"LV Nalla","year":"2019","unstructured":"Nalla LV, Kalia K, Khairnar A (2019) Self-renewal signaling pathways in breast cancer stem cells. Int J Biochem Cell Biol 107:140\u2013153","journal-title":"Int J Biochem Cell Biol"},{"issue":"10","key":"6_CR151","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrd3554","volume":"10","author":"D Neri","year":"2011","unstructured":"Neri D, Supuran CT (2011) Interfering with pH regulation in tumours as a therapeutic strategy. Nat Rev Drug Discov 10(10):767\u2013777","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"6_CR152","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton K, Strasser A, Kayagaki N, Dixit VM (2024) Cell death. Cell 187(2):235\u2013256","journal-title":"Cell"},{"issue":"1","key":"6_CR153","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12931-015-0234-2","volume":"16","author":"E Nigro","year":"2015","unstructured":"Nigro E, Imperlini E, Scudiero O, Monaco ML, Polito R, Mazzarella G, Orr\u00f9 S, Bianco A, Daniele A (2015) Differentially expressed and activated proteins associated with non small cell lung cancer tissues. Respir Res 16(1):74","journal-title":"Respir Res"},{"issue":"3","key":"6_CR154","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/mc.20264","volume":"46","author":"M Nishikata","year":"2007","unstructured":"Nishikata M, Nishimori I, Taniuchi K, Takeuchi T, Minakuchi T, Kohsaki T, Adachi Y, Ohtsuki Y, Onishi S (2007) Carbonic anhydrase-related protein VIII promotes colon cancer cell growth. Mol Carcinog 46(3):208\u2013214","journal-title":"Mol Carcinog"},{"issue":"12","key":"6_CR155","doi-asserted-by":"publisher","first-page":"5380","DOI":"10.1021\/acs.jmedchem.8b00625","volume":"61","author":"A Nocentini","year":"2018","unstructured":"Nocentini A, Ceruso M, Bua S, Lomelino CL, Andring JT, McKenna R, Lanzi C, Sgambellone S, Pecori R, Matucci R, Filippi L, Gratteri P, Carta F, Masini E, Selleri S, Supuran CT (2018) Discovery of \u03b2-adrenergic receptors blocker-carbonic anhydrase inhibitor hybrids for multitargeted Antiglaucoma therapy. J Med Chem 61(12):5380\u20135394","journal-title":"J Med Chem"},{"issue":"1","key":"6_CR156","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1080\/14756366.2021.1882453","volume":"36","author":"A Nocentini","year":"2021","unstructured":"Nocentini A, Angeli A, Carta F, Winum JY, Zalubovskis R, Carradori S, Capasso C, Donald WA, Supuran CT (2021) Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. J Enzyme Inhib Med Chem 36(1):561\u2013580","journal-title":"J Enzyme Inhib Med Chem"},{"key":"6_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.145034","volume":"762","author":"D Okuyan","year":"2020","unstructured":"Okuyan D, Aydogan Turkoglu S, Kockar F (2020) Carbonic anhydrase III is a new target of HIF1\u03b1 in prostate cancer model. Gene 762:145034","journal-title":"Gene"},{"issue":"4","key":"6_CR158","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/ijc.2910380406","volume":"38","author":"E Oosterwijk","year":"1986","unstructured":"Oosterwijk E, Ruiter DJ, Hoedemaeker PJ, Pauwels EK, Jonas U, Zwartendijk J, Warnaar SO (1986) Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int J Cancer 38(4):489\u2013494","journal-title":"Int J Cancer"},{"issue":"4","key":"6_CR159","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1200\/JCO.1993.11.4.738","volume":"11","author":"E Oosterwijk","year":"1993","unstructured":"Oosterwijk E, Bander NH, Divgi CR, Welt S, Wakka JC, Finn RD, Carswell EA, Larson SM, Warnaar SO, Fleuren GJ et al (1993) Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250. J Clin Oncol 11(4):738\u2013750","journal-title":"J Clin Oncol"},{"issue":"6","key":"6_CR160","doi-asserted-by":"publisher","first-page":"11402","DOI":"10.3390\/ijms140611402","volume":"14","author":"JC Oosterwijk-Wakka","year":"2013","unstructured":"Oosterwijk-Wakka JC, Boerman OC, Mulders PF, Oosterwijk E (2013) Application of monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinoma. Int J Mol Sci 14(6):11402\u201311423","journal-title":"Int J Mol Sci"},{"issue":"2","key":"6_CR161","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/14756366.2013.773994","volume":"29","author":"J Pan","year":"2014","unstructured":"Pan J, Lau J, Mesak F, Hundal N, Pourghiasian M, Liu Z, B\u00e9nard F, Dedhar S, Supuran CT, Lin KS (2014) Synthesis and evaluation of 18F-labeled carbonic anhydrase IX inhibitors for imaging with positron emission tomography. J Enzyme Inhib Med Chem 29(2):249\u2013255","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"7","key":"6_CR162","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1177\/38.7.2113069","volume":"38","author":"S Parkkila","year":"1990","unstructured":"Parkkila S, Kaunisto K, Rajaniemi L, Kumpulainen T, Jokinen K, Rajaniemi H (1990) Immunohistochemical localization of carbonic anhydrase isoenzymes VI, II, and I in human parotid and submandibular glands. J Histochem Cytochem 38(7):941\u2013947","journal-title":"J Histochem Cytochem"},{"issue":"9","key":"6_CR163","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1002\/jcp.24346","volume":"228","author":"SK Parks","year":"2013","unstructured":"Parks SK, Mazure NM, Counillon L, Pouyss\u00e9gur J (2013) Hypoxia promotes tumor cell survival in acidic conditions by preserving ATP levels. J Cell Physiol 228(9):1854\u20131862","journal-title":"J Cell Physiol"},{"issue":"5","key":"6_CR164","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s11248-016-9961-5","volume":"25","author":"MS Patrikainen","year":"2016","unstructured":"Patrikainen MS, Pan P, Barker HR, Parkkila S (2016) Altered gene expression in the lower respiratory tract of Car6 (\u2212\/\u2212) mice. Transgenic Res 25(5):649\u2013664","journal-title":"Transgenic Res"},{"issue":"5","key":"6_CR165","doi-asserted-by":"publisher","first-page":"615e9","DOI":"10.1007\/s11307-015-0831-y","volume":"17","author":"SG Peeters","year":"2015","unstructured":"Peeters SG, Dubois L, Lieuwes NG, Laan D, Mooijer M, Schuit RC et al (2015) [(18)F]VM4-037 MicroPET imaging and biodistribution of two in vivo CAIX-expressing tumor models. Mol Imaging Biol 17(5):615e9","journal-title":"Mol Imaging Biol"},{"issue":"2","key":"6_CR166","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1158\/1535-7163.MCT-11-0523","volume":"11","author":"HM Petrul","year":"2012","unstructured":"Petrul HM, Schatz CA, Kopitz CC, Adnane L, McCabe TJ, Trail P, Ha S, Chang YS, Voznesensky A, Ranges G, Tamburini PP (2012) Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9. Mol Cancer Ther 11(2):340\u2013349","journal-title":"Mol Cancer Ther"},{"issue":"4","key":"6_CR167","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.acthis.2011.08.004","volume":"114","author":"M Piras","year":"2012","unstructured":"Piras M, Tandler B, Barbarossa IT, Piludu M (2012) Immunogold labeling of carbonic anhydrase isozyme (CA-VI) in secretory granules of human parotid glands. Acta Histochem 114(4):406\u2013408","journal-title":"Acta Histochem"},{"issue":"15","key":"6_CR168","doi-asserted-by":"publisher","first-page":"11432","DOI":"10.1021\/acs.jmedchem.1c00756","volume":"64","author":"AA Plyasova","year":"2021","unstructured":"Plyasova AA, Berrino E, Khan II, Veselovsky AV, Pokrovsky VS, Angeli A, Ferraroni M, Supuran CT, Pokrovskaya MV, Alexandrova SS, Gladilina YA, Sokolov NN, Hilal A, Carta F, Zhdanov DD (2021) Mechanisms of the antiproliferative and antitumor activity of novel telomerase-carbonic anhydrase dual-hybrid inhibitors. J Med Chem 64(15):11432\u201311444","journal-title":"J Med Chem"},{"issue":"7092","key":"6_CR169","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/nature04871","volume":"441","author":"J Pouyss\u00e9gur","year":"2006","unstructured":"Pouyss\u00e9gur J, Dayan F, Mazure NM (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441(7092):437\u2013443","journal-title":"Nature"},{"issue":"11","key":"6_CR170","doi-asserted-by":"publisher","first-page":"1780e8","DOI":"10.1002\/cmdc.200800267","volume":"3","author":"M Rami","year":"2008","unstructured":"Rami M, Cecchi A, Montero JL, Innocenti A, Vullo D, Scozzafava A et al (2008) Carbonic anhydrase inhibitors: design of membrane-impermeant copper(II) complexes of DTPA-, DOTA-, and TETA-tailed sulfonamides targeting the tumor-associated transmembrane isoform IX. ChemMedChem 3(11):1780e8","journal-title":"ChemMedChem"},{"key":"6_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118107","volume":"300","author":"G Renzi","year":"2025","unstructured":"Renzi G, McDonald PC, Awrey S, Tavakoli H, Bokhari Z, Lyle M, Zhang Z, Ferraroni M, Dedhar S, Supuran CT, Angeli A (2025) Dual inhibition of carbonic anhydrase IX and glutathione peroxidase 4 as a novel strategy for ferroptosis-induced tumor cell death. Eur J Med Chem 300:118107","journal-title":"Eur J Med Chem"},{"issue":"4","key":"6_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189120","volume":"1879","author":"R Ronca","year":"2024","unstructured":"Ronca R, Supuran CT (2024) Carbonic anhydrase IX: an atypical target for innovative therapies in cancer. Biochim Biophys Acta Rev Cancer 1879(4):189120","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"31","key":"6_CR173","doi-asserted-by":"publisher","first-page":"12744","DOI":"10.1074\/jbc.R117.789537","volume":"292","author":"TA Rouault","year":"2017","unstructured":"Rouault TA, Maio N (2017) Biogenesis and functions of mammalian iron-sulfur proteins in the regulation of iron homeostasis and pivotal metabolic pathways. J Biol Chem 292(31):12744\u201312753","journal-title":"J Biol Chem"},{"issue":"7","key":"6_CR174","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.3390\/cancers17071190","volume":"17","author":"C Rousseau","year":"2025","unstructured":"Rousseau C, Baumgartner P, Heymann MF, Taupin M, Geffroy M, Chatal JF, Gautier G, Allam N, Gaschet J, Eychenne R, Gu\u00e9rard F, Gestin JF, Varmenot N, Ch\u00e9rel M (2025) Preclinical and clinical feasibility studies as the first step before forthcoming intravesical instillation of [211At]At-anti-CA-IX antibody (ATO-101\u2122) study in patients with non-muscle-invasive bladder cancer unresponsive to standard of care. Cancers (Basel) 17(7):1190","journal-title":"Cancers (Basel)"},{"key":"6_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115707","volume":"259","author":"S Saied","year":"2023","unstructured":"Saied S, Shaldam M, Elbadawi MM, Giovannuzzi S, Nocentini A, Almahli H, Salem R, Ibrahim TM, Supuran CT, Eldehna WM (2023) Discovery of indolinone-bearing benzenesulfonamides as new dual carbonic anhydrase and VEGFR-2 inhibitors possessing anticancer and pro-apoptotic properties. Eur J Med Chem 259:115707","journal-title":"Eur J Med Chem"},{"issue":"2","key":"6_CR176","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2174\/1871520616666161031143301","volume":"17","author":"L Schwartz","year":"2017","unstructured":"Schwartz L, Supuran CT, Alfarouk KO (2017) The Warburg effect and the hallmarks of cancer. Anti Cancer Agents Med Chem 17(2):164\u2013170","journal-title":"Anti Cancer Agents Med Chem"},{"issue":"4","key":"6_CR177","first-page":"701","volume":"19","author":"K Shiozaki","year":"2001","unstructured":"Shiozaki K, Nakamori S, Tsujie M, Okami J, Yamamoto H, Nagano H, Dono K, Umeshita K, Sakon M, Furukawa H, Hiratsuka M, Kasugai T, Ishiguro S, Monden M (2001) Human stomach-specific gene, CA11, is down-regulated in gastric cancer. Int J Oncol 19(4):701\u2013707","journal-title":"Int J Oncol"},{"issue":"10","key":"6_CR178","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/S1470-2045(24)00402-9","volume":"25","author":"B Shuch","year":"2024","unstructured":"Shuch B, Pantuck AJ, Bernhard JC, Morris MA, Master V, Scott AM, van Praet C, Bailly C, \u00d6nal B, Aksoy T, Merkx R, Schuster DM, Lee ST, Pandit-Taskar N, Fan AC, Allman P, Schmidt K, Tauchmanova L, Wheatcroft M, Behrenbruch C, Hayward CRW, Mulders P (2024) [89Zr]Zr-girentuximab for PET-CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial. Lancet Oncol 25(10):1277\u20131287","journal-title":"Lancet Oncol"},{"issue":"1","key":"6_CR179","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00345-010-0570-2","volume":"29","author":"M Siebels","year":"2011","unstructured":"Siebels M, Rohrmann K, Oberneder R, Stahler M, Haseke N, Beck J, Hofmann R, Kindler M, Kloepfer P, Stief C (2011) A clinical phase I\/II trial with the monoclonal antibody cG250 (RENCAREX\u00ae) and interferon-alpha-2a in metastatic renal cell carcinoma patients. World J Urol 29(1):121\u2013126","journal-title":"World J Urol"},{"key":"6_CR180","first-page":"395","volume":"6","author":"MC Smaldone","year":"2012","unstructured":"Smaldone MC, Chen DY, Yu JQ, Plimack ER (2012) Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer. Biologics 6:395\u2013407","journal-title":"Biologics"},{"issue":"13","key":"6_CR181","doi-asserted-by":"publisher","first-page":"6431","DOI":"10.1021\/acs.jmedchem.6b00623","volume":"59","author":"D Sneddon","year":"2016","unstructured":"Sneddon D, Niemans R, Bauwens M, Yaromina A, van Kuijk SJ, Lieuwes NG, Biemans R, Pooters I, Pellegrini PA, Lengkeek NA, Greguric I, Tonissen KF, Supuran CT, Lambin P, Dubois L, Poulsen SA (2016) Synthesis and in vivo biological evaluation of (68)Ga-labeled carbonic anhydrase IX targeting small molecules for positron emission tomography. J Med Chem 59(13):6431\u20136443","journal-title":"J Med Chem"},{"issue":"12","key":"6_CR182","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","volume":"16","author":"M Soula","year":"2020","unstructured":"Soula M, Weber RA, Zilka O, Alwaseem H, La K, Yen F, Molina H, Garcia-Bermudez J, Pratt DA, Birsoy K (2020) Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat Chem Biol 16(12):1351\u20131360","journal-title":"Nat Chem Biol"},{"issue":"4","key":"6_CR183","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1200\/JCO.1997.15.4.1529","volume":"15","author":"MG Steffens","year":"1997","unstructured":"Steffens MG, Boerman OC, Oosterwijk-Wakka JC, Oosterhof GO, Witjes JA, Koenders EB, Oyen WJ, Buijs WC, Debruyne FM, Corstens FH, Oosterwijk E (1997) Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250. J Clin Oncol 15(4):1529\u20131537","journal-title":"J Clin Oncol"},{"issue":"2","key":"6_CR184","first-page":"133","volume":"13","author":"MG Steffens","year":"1998","unstructured":"Steffens MG, Kranenborg MH, Boerman OC, Zegwaart-Hagemeier NE, Debruyne FM, Corstens FH, Oosterwijk E (1998) Tumor retention of 186Re-MAG3, 111In-DTPA and 125I labeled monoclonal antibody G250 in nude mice with renal cell carcinoma xenografts. Cancer Biother Radiopharm 13(2):133\u2013139","journal-title":"Cancer Biother Radiopharm"},{"issue":"10 Suppl","key":"6_CR185","first-page":"3268s","volume":"5","author":"MG Steffens","year":"1999","unstructured":"Steffens MG, Boerman OC, de Mulder PH, Oyen WJ, Buijs WC, Witjes JA, van den Broek WJ, Oosterwijk-Wakka JC, Debruyne FM, Corstens FH, Oosterwijk E (1999) Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250. Clin Cancer Res 5(10 Suppl):3268s\u20133274s","journal-title":"Clin Cancer Res"},{"issue":"5","key":"6_CR186","first-page":"829","volume":"40","author":"MG Steffens","year":"1999","unstructured":"Steffens MG, Oosterwijk E, Kranenborg MH, Manders JM, Debruyne FM, Corstens FH, Boerman OC (1999) In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations. J Nucl Med 40(5):829\u2013836","journal-title":"J Nucl Med"},{"issue":"1","key":"6_CR187","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2967\/jnumed.111.094896","volume":"53","author":"AB Stillebroer","year":"2012","unstructured":"Stillebroer AB, Zegers CM, Boerman OC, Oosterwijk E, Mulders PF, O'Donoghue JA, Visser EP, Oyen WJ (2012) Dosimetric analysis of 177Lu-cG250 radioimmunotherapy in renal cell carcinoma patients: correlation with myelotoxicity and pretherapeutic absorbed dose predictions based on 111In-cG250 imaging. J Nucl Med 53(1):82\u201389","journal-title":"J Nucl Med"},{"issue":"7","key":"6_CR188","first-page":"510","volume":"28","author":"AB Stillebroer","year":"2013","unstructured":"Stillebroer AB, Franssen GM, Mulders PF, Oyen WJ, van Dongen GA, Laverman P, Oosterwijk E, Boerman OC (2013) ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in mice. Cancer Biother Radiopharm 28(7):510\u2013515","journal-title":"Cancer Biother Radiopharm"},{"key":"6_CR189","doi-asserted-by":"publisher","DOI":"10.1016\/S0223-5234(98)80042-1","volume":"33","author":"CT Supuran","year":"1998","unstructured":"Supuran CT, Ilies MA, Scozzafava A (1998) Carbonic anhydrase inhibitors - Part 29:Interaction of isozymes I, II and IV with benzolamide-like derivatives. Eur J Med Chem 33:739e51","journal-title":"Eur J Med Chem"},{"key":"6_CR190","first-page":"577e94","volume":"33","author":"CT Supuran","year":"1998","unstructured":"Supuran CT, Scozzafava A, Ilies MA, Iorga B, Cristea T, Briganti F et al (1998) Carbonic anhydrase inhibitors - Part 53 - synthesis of substituted-pyridinium derivatives of aromatic sulfonamides: the first non-polymeric membrane-impermeable inhibitors with selectivity for isozyme IV. Eur J Med Chem 33:577e94","journal-title":"Eur J Med Chem"},{"issue":"2","key":"6_CR191","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"CT Supuran","year":"2008","unstructured":"Supuran CT (2008) Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 7(2):168\u2013181","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"6_CR192","first-page":"48","volume":"7","author":"CT Supuran","year":"2017","unstructured":"Supuran CT (2017) Carbonic anhydrase inhibition and the management of hypoxic tumors. Meta 7(3):48","journal-title":"Meta"},{"key":"6_CR193","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2023.129411","volume":"93","author":"CT Supuran","year":"2023","unstructured":"Supuran CT (2023) A simple yet multifaceted 90 years old, evergreen enzyme: carbonic anhydrase, its inhibition and activation. Bioorg Med Chem Lett 93:129411","journal-title":"Bioorg Med Chem Lett"},{"issue":"3","key":"6_CR194","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","volume":"577","author":"E Svastov\u00e1","year":"2004","unstructured":"Svastov\u00e1 E, Hul\u00edkov\u00e1 A, Rafajov\u00e1 M, Zat\u2019ovicov\u00e1 M, Gibadulinov\u00e1 A, Casini A, Cecchi A, Scozzafava A, Supuran CT, Pastorek J, Pastorekov\u00e1 S (2004) Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett 577(3):439\u2013445","journal-title":"FEBS Lett"},{"issue":"45","key":"6_CR195","doi-asserted-by":"publisher","first-page":"6244","DOI":"10.1038\/onc.2017.219","volume":"36","author":"M Swayampakula","year":"2017","unstructured":"Swayampakula M, McDonald PC, Vallejo M, Coyaud E, Chafe SC, Westerback A, Venkateswaran G, Shankar J, Gao G, Laurent EMN, Lou Y, Bennewith KL, Supuran CT, Nabi IR, Raught B, Dedhar S (2017) The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia\/MMP14-mediated invasion. Oncogene 36(45):6244\u20136261","journal-title":"Oncogene"},{"issue":"5","key":"6_CR196","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/1878-0261.12445","volume":"13","author":"B Tao","year":"2019","unstructured":"Tao B, Ling Y, Zhang Y, Li S, Zhou P, Wang X, Li B, Jun Z, Zhang W, Xu C, Shi J, Wang L, Zhang W, Li S (2019) CA10 and CA11 negatively regulate neuronal activity-dependent growth of gliomas. Mol Oncol 13(5):1018\u20131032","journal-title":"Mol Oncol"},{"issue":"7","key":"6_CR197","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3390\/molecules25071748","volume":"25","author":"E Teodori","year":"2020","unstructured":"Teodori E, Braconi L, Bua S, Lapucci A, Bartolucci G, Manetti D, Romanelli MN, Dei S, Supuran CT, Coronnello M (2020) Dual P-glycoprotein and CA XII inhibitors: a new strategy to reverse the P-gp mediated multidrug resistance (MDR) in cancer cells. Molecules 25(7):1748","journal-title":"Molecules"},{"issue":"1","key":"6_CR198","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00261-015-0599-1","volume":"41","author":"B Turkbey","year":"2016","unstructured":"Turkbey B, Lindenberg ML, Adler S, Kurdziel KA, McKinney YL, Weaver J, Vocke CD, Anver M, Bratslavsky G, Eclarinal P, Kwarteng G, Lin FI, Yaqub-Ogun N, Merino MJ, Linehan WM, Choyke PL, Metwalli AR (2016) PET\/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot study. Abdom Radiol (NY) 41(1):109\u2013118","journal-title":"Abdom Radiol (NY)"},{"issue":"13","key":"6_CR199","doi-asserted-by":"publisher","first-page":"7608","DOI":"10.1073\/pnas.95.13.7608","volume":"95","author":"O T\u00fcreci","year":"1998","unstructured":"T\u00fcreci O, Sahin U, Vollmar E, Siemer S, G\u00f6ttert E, Seitz G, Parkkila AK, Shah GN, Grubb JH, Pfreundschuh M, Sly WS (1998) Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci USA 95(13):7608\u20137613","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"6_CR200","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1158\/1078-0432.CCR-05-2253","volume":"12","author":"H Uemura","year":"2006","unstructured":"Uemura H, Fujimoto K, Tanaka M, Yoshikawa M, Hirao Y, Uejima S, Yoshikawa K, Itoh K (2006) A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma. Clin Cancer Res 12(6):1768\u20131775","journal-title":"Clin Cancer Res"},{"issue":"6352","key":"6_CR201","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan2507","volume":"357","author":"M Uhlen","year":"2017","unstructured":"Uhlen M, Zhang C, Lee S, Sj\u00f6stedt E, Fagerberg L, Bidkhori G, Benfeitas R, Arif M, Liu Z, Edfors F, Sanli K, von Feilitzen K, Oksvold P, Lundberg E, Hober S, Nilsson P, Mattsson J, Schwenk JM, Brunnstr\u00f6m H, Glimelius B, Sj\u00f6blom T, Edqvist PH, Djureinovic D, Micke P, Lindskog C, Mardinoglu A, Ponten F (2017) A pathology atlas of the human cancer transcriptome. Science 357(6352):eaan2507","journal-title":"Science"},{"issue":"3","key":"6_CR202","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/MOU.0000000000000872","volume":"31","author":"T van Oostenbrugge","year":"2021","unstructured":"van Oostenbrugge T, Mulders P (2021) Targeted PET\/CT imaging for clear cell renal cell carcinoma with radiolabeled antibodies: recent developments using girentuximab. Curr Opin Urol 31(3):249\u2013254","journal-title":"Curr Opin Urol"},{"issue":"10","key":"6_CR203","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1158\/1535-7163.MCT-23-0041","volume":"22","author":"G Venkateswaran","year":"2023","unstructured":"Venkateswaran G, McDonald PC, Chafe SC, Brown WS, Gerbec ZJ, Awrey SJ, Parker SJ, Dedhar S (2023) A carbonic anhydrase IX\/SLC1A5 Axis regulates glutamine metabolism dependent Ferroptosis in hypoxic tumor cells. Mol Cancer Ther 22(10):1228\u20131242","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"6_CR204","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s00259-019-04358-9","volume":"46","author":"SR Verhoeff","year":"2019","unstructured":"Verhoeff SR, van Es SC, Boon E, van Helden E, Angus L, Elias SG, Oosting SF, Aarntzen EH, Brouwers AH, Kwee TC, Heskamp S, Hoekstra OS, Verheul H, van der Veldt AAM, de Vries EGE, Boerman OC, van der Graaf WTA, Oyen WJG, van Herpen CML (2019) Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET\/CT in patients with newly diagnosed metastatic renal cell carcinoma. Eur J Nucl Med Mol Imaging 46(9):1931\u20131939","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"6_CR205","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1002\/ijc.31607","volume":"143","author":"B von Neubeck","year":"2018","unstructured":"von Neubeck B, Gondi G, Riganti C, Pan C, Parra Damas A, Scherb H, Ert\u00fcrk A, Zeidler R (2018) An inhibitory antibody targeting carbonic anhydrase XII abrogates chemoresistance and significantly reduces lung metastases in an orthotopic breast cancer model in vivo. Int J Cancer 143(8):2065\u20132075","journal-title":"Int J Cancer"},{"key":"6_CR206","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.gene.2017.04.027","volume":"623","author":"A Waheed","year":"2017","unstructured":"Waheed A, Sly WS (2017) Carbonic anhydrase XII functions in health and disease. Gene 623:33\u201340","journal-title":"Gene"},{"issue":"12","key":"6_CR207","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/s41568-025-00864-1","volume":"25","author":"A Wahida","year":"2025","unstructured":"Wahida A, Conrad M (2025) Decoding ferroptosis for cancer therapy. Nat Rev Cancer 25(12):910\u2013924. https:\/\/doi.org\/10.1038\/s41568-025-00864-1","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"6_CR208","first-page":"4","volume":"20","author":"B Wang","year":"2020","unstructured":"Wang B, Jiang H, Wan X, Wang Y, Zheng X, Li P, Guo J, Ding X, Song H (2020) Carbonic anhydrase IV inhibits cell proliferation in gastric cancer by regulating the cell cycle. Oncol Lett 20(4):4","journal-title":"Oncol Lett"},{"issue":"1","key":"6_CR209","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s13277-015-3834-z","volume":"37","author":"DB Wang","year":"2016","unstructured":"Wang DB, Lu XK, Zhang X, Li ZG, Li CX (2016) Carbonic anhydrase 1 is a promising biomarker for early detection of non-small cell lung cancer. Tumour Biol 37(1):553\u2013559","journal-title":"Tumour Biol"},{"issue":"6","key":"6_CR210","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1177\/030089161209800617","volume":"98","author":"N Wang","year":"2012","unstructured":"Wang N, Chen Y, Han Y, Zhao Y, Liu Y, Guo K, Jiang Y (2012) Proteomic analysis shows down-regulations of cytoplasmic carbonic anhydrases, CAI and CAII, are early events of colorectal carcinogenesis but are not correlated with lymph node metastasis. Tumori 98(6):783\u2013791","journal-title":"Tumori"},{"key":"6_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.114039","volume":"228","author":"Y Wang","year":"2022","unstructured":"Wang Y, Tortorella M (2022) Molecular design of dual inhibitors of PI3K and potential molecular target of cancer for its treatment: a review. Eur J Med Chem 228:114039","journal-title":"Eur J Med Chem"},{"key":"6_CR212","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.599281","volume":"8","author":"X Wang","year":"2020","unstructured":"Wang X, Bove AM, Simone G, Ma B (2020) Molecular bases of VEGFR-2-mediated physiological function and pathological role. Front Cell Dev Biol 8:599281","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"6_CR213","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nchem.2158","volume":"7","author":"M Wichert","year":"2015","unstructured":"Wichert M, Krall N, Decurtins W, Franzini RM, Pretto F, Schneider P, Neri D, Scheuermann J (2015) Dual-display of small molecules enables the discovery of ligand pairs and facilitates affinity maturation. Nat Chem 7(3):241\u2013249","journal-title":"Nat Chem"},{"issue":"24","key":"6_CR214","first-page":"7075","volume":"60","author":"CC Wykoff","year":"2000","unstructured":"Wykoff CC, Beasley NJ, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson GD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL (2000) Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60(24):7075\u20137083","journal-title":"Cancer Res"},{"key":"6_CR215","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/0470868716.ch15","volume":"240","author":"CC Wykoff","year":"2001","unstructured":"Wykoff CC, Pugh CW, Harris AL, Maxwell PH, Ratcliffe PJ (2001) The HIF pathway: implications for patterns of gene expression in cancer. Novartis Found Symp 240:212\u2013225","journal-title":"Novartis Found Symp"},{"key":"6_CR216","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118522","volume":"262","author":"MM Wu","year":"2020","unstructured":"Wu MM, Zhang Z, Tong CWS, Yan VW, Cho WCS, To KKW (2020) Repurposing of niclosamide as a STAT3 inhibitor to enhance the anticancer effect of chemotherapeutic drugs in treating colorectal cancer. Life Sci 262:118522","journal-title":"Life Sci"},{"issue":"20","key":"6_CR217","doi-asserted-by":"publisher","first-page":"6101","DOI":"10.7150\/jca.46902","volume":"11","author":"Y Xu","year":"2020","unstructured":"Xu Y, Xu WH, Shi SN, Yang XL, Ren YR, Zhuang XY, Qu YY, Zhang HL, Zhang XF (2020) Carbonic anhydrase 4 serves as a clinicopathological biomarker for outcomes and immune infiltration in renal cell carcinoma, lower grade glioma, lung adenocarcinoma and uveal melanoma. J Cancer 11(20):6101\u20136113","journal-title":"J Cancer"},{"issue":"3","key":"6_CR218","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.21037\/jgo-23-405","volume":"14","author":"F Xue","year":"2023","unstructured":"Xue F, Jiang J, Kou J (2023) Screening of key genes related to ferroptosis and a molecular interaction network analysis in colorectal cancer using machine learning and bioinformatics. J Gastrointest Oncol 14(3):1346\u20131359","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"6_CR219","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114392","volume":"444","author":"J Yan","year":"2025","unstructured":"Yan J, Zhou Y, Xu J, Dong Y, Yang X, Yang X, Wu A, Chang S, Wang Y, Zhang Q, Ayaka T, Yu L, Zhao L, Meng H, Liu D (2025) Delactylation diminished the growth inhibitory role of CA3 by restoring DUOX2 expression in hepatocellular carcinoma. Exp Cell Res 444(2):114392","journal-title":"Exp Cell Res"},{"key":"6_CR220","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12885-015-1216-y","volume":"15","author":"GZ Yang","year":"2015","unstructured":"Yang GZ, Hu L, Cai J, Chen HY, Zhang Y, Feng D, Qi CY, Zhai YX, Gong H, Fu H, Cai QP, Gao CF (2015) Prognostic value of carbonic anhydrase VII expression in colorectal carcinoma. BMC Cancer 15:209","journal-title":"BMC Cancer"},{"issue":"32","key":"6_CR221","doi-asserted-by":"publisher","first-page":"33733","DOI":"10.18632\/oncotarget.5254","volume":"6","author":"X Yang","year":"2015","unstructured":"Yang X, Minn I, Rowe SP, Banerjee SR, Gorin MA, Brummet M, Lee HS, Koo SM, Sysa-Shah P, Mease RC, Nimmagadda S, Allaf ME, Pomper MG (2015) Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor. Oncotarget 6(32):33733\u201333742","journal-title":"Oncotarget"},{"issue":"11","key":"6_CR222","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nrc3818","volume":"14","author":"H Yu","year":"2014","unstructured":"Yu H, Lee H, Herrmann A, Buettner R, Jove R (2014) Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer 14(11):736\u2013746","journal-title":"Nat Rev Cancer"},{"issue":"13\u201315","key":"6_CR223","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1089\/ars.2024.0693","volume":"41","author":"Y Yu","year":"2024","unstructured":"Yu Y, Poulsen SA, Di Trapani G, Tonissen KF (2024) Exploring the redox and pH dimension of carbonic anhydrases in cancer: a focus on carbonic anhydrase 3. Antioxid Redox Signal 41(13\u201315):957\u2013975","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"6_CR224","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","volume":"25","author":"J Yuan","year":"2024","unstructured":"Yuan J, Ofengeim D (2024) A guide to cell death pathways. Nat Rev Mol Cell Biol 25(5):379\u2013395","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"6_CR225","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1054\/bjoc.2000.1111","volume":"82","author":"J Z\u00e1vada","year":"2000","unstructured":"Z\u00e1vada J, Z\u00e1vadov\u00e1 Z, Pastorek J, Biesov\u00e1 Z, Jezek J, Velek J (2000) Human tumour-associated cell adhesion protein MN\/CA IX: identification of M75 epitope and of the region mediating cell adhesion. Br J Cancer 82(11):1808\u20131813","journal-title":"Br J Cancer"},{"issue":"8","key":"6_CR226","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.70030","volume":"85","author":"M Zengin","year":"2024","unstructured":"Zengin M, Unsal Tan O, Sabuncuoglu S, Arafa RK, Balkan A (2024) Design and discovery of new dual carbonic anhydrase IX and VEGFR-2 inhibitors based on the Benzenesulfonamide-bearing 4-Thiazolidinones\/2,4-Thiazolidinediones scaffold. Drug Dev Res 85(8):e70030","journal-title":"Drug Dev Res"},{"issue":"9","key":"6_CR227","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1136\/gutjnl-2014-308614","volume":"65","author":"J Zhang","year":"2016","unstructured":"Zhang J, Tsoi H, Li X, Wang H, Gao J, Wang K, Go MY, Ng SC, Chan FK, Sung JJ, Yu J (2016) Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP-WT1-TBL1 axis. Gut 65(9):1482\u20131493","journal-title":"Gut"},{"issue":"1","key":"6_CR228","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1080\/14756366.2017.1308928","volume":"32","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Lau J, Zhang C, Colpo N, Nocentini A, Supuran CT, B\u00e9nard F, Lin KS (2017) Design, synthesis and evaluation of 18F-labeled cationic carbonic anhydrase IX inhibitors for PET imaging. J Enzyme Inhib Med Chem 32(1):722\u2013730","journal-title":"J Enzyme Inhib Med Chem"},{"key":"6_CR229","doi-asserted-by":"publisher","first-page":"1367938","DOI":"10.1155\/2023\/1367938","volume":"2023","author":"C Zhang","year":"2023","unstructured":"Zhang C, Lu X, Liu X, Xu J, Li J, Qu T, Dai J, Guo R (2023) Carbonic anhydrase IX controls vulnerability to Ferroptosis in Gefitinib-resistant lung cancer. Oxidative Med Cell Longev 2023:1367938","journal-title":"Oxidative Med Cell Longev"},{"key":"6_CR230","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1186\/s12885-015-1707-x","volume":"15","author":"Y Zheng","year":"2015","unstructured":"Zheng Y, Xu B, Zhao Y, Gu H, Li C, Wang Y, Chang X (2015) CA1 contributes to microcalcification and tumourigenesis in breast cancer. BMC Cancer 15:679","journal-title":"BMC Cancer"},{"issue":"7","key":"6_CR231","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3390\/cells12071050","volume":"12","author":"X Zheng","year":"2023","unstructured":"Zheng X, Liang Y, Zhang C (2023) Ferroptosis regulated by hypoxia in cells. Cells 12(7):1050","journal-title":"Cells"},{"issue":"3","key":"6_CR232","doi-asserted-by":"publisher","first-page":"R40","DOI":"10.1186\/bcr2091","volume":"10","author":"L Zhong","year":"2008","unstructured":"Zhong L, Ge K, Zu JC, Zhao LH, Shen WK, Wang JF, Zhang XG, Gao X, Hu W, Yen Y, Kernstine KH (2008) Autoantibodies as potential biomarkers for breast cancer. Breast Cancer Res 10(3):R40","journal-title":"Breast Cancer Res"},{"issue":"41","key":"6_CR233","doi-asserted-by":"publisher","first-page":"16158","DOI":"10.1073\/pnas.0702596104","volume":"104","author":"J Zhou","year":"2007","unstructured":"Zhou J, Wulfkuhle J, Zhang H, Gu P, Yang Y, Deng J, Margolick JB, Liotta LA, Petricoin E 3rd, Zhang Y (2007) Activation of the PTEN\/mTOR\/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci USA 104(41):16158\u201316163","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Subcellular Biochemistry","Carbonic Anhydrase Inhibitors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-23172-7_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:50:46Z","timestamp":1777596646000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-23172-7_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032231710","9783032231727"],"references-count":233,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-23172-7_6","relation":{},"ISSN":["0306-0225","2542-8810"],"issn-type":[{"value":"0306-0225","type":"print"},{"value":"2542-8810","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}